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Summary 
Modern drug design and discovery not only focus on the pharmacological activity 
of a compound, but also take its pharmacokinetic behavior into account. The prediction 
of in vivo barrier permeation, particularly intestinal absorption and blood-brain barrier 
passage, are substantial concerns in the development of new drug compounds. For 
several decades, lipophilicity expressed as n-octanol/water partition coefficient (log Poct) 
dominated absorption prediction schemes, since partitioning in this solvent system is 
traditionally accepted as an informative model of membrane partitioning. Recent 
advances in automated synthesis and combinatorial chemistry result in a vast number of 
potential drug candidates, and thus the demand for fast and reliable methods to measure 
this parameter has grown rapidly in recent years. 
However, in many relevant cases especially for the structurally unrelated or 
ionized compounds, log Poct can not give a good estimate of a drug´s absorption or 
permeation. Indeed, the isotropic n-octanol/water system can only roughly mimic natural 
membrane barriers, which are made of ordered and anisotropic lipid membranes. 
Therefore bio-mimicking artificial membrane systems have been developed for a better 
prediction of drug absorption. 
The objective of this work is to further develop the present high-throughput 
techniques to measure relevant lipophilicity indices, and more importantly to understand 
the structural properties encoded in lipophilicity indices derived from different systems. 
This is important for designing better-suited drugs for medical therapy by improving the 
biopharmaceutical properties of the drugs via their chemical structure modifications. 
Chapter 1 gives a brief description of drug permeation and lipophilicity, and the 
relationship between them. Chapter 2 reviews the high-throughput chromatographic 
approaches to assess drug partition into biomembranes. 
The habilitation thesis consists of three parts of work. First, we investigated 
thoroughly the optimal conditions of the high-throughput reversed-phase high 
performance liquid chromatography (RP-HPLC) method for the measurement of log Poct 
values. Our studies revealed that under optimal mobile phase and stationary phase 
conditions, RP-HPLC is a powerful method for the efficient and accurate determination 
of log Poct values, and that partitioning of the compounds in the RP-HPLC system is 
controlled by the same balance of intermolecular forces (Van der Waals volume, H-bond 
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acceptor basicity and dipolarity/polarizability) as in n-octanol/water system by 
quantitative structure-property relationship analysis (Publications 1-4).  
Second, a flow ratiometry technique was also developed for the quick 
determination of the partition coefficient of the volatile compounds (Publication 5). 
Third, we investigated drug-membrane interactions by using artificial membrane 
systems including immobilized artificial membrane (IAM) chromatography and 
immobilized liposome chromatography (ILC). The lipophilicity indices from these 
artificial membrane systems were compared to that from n-octanol/water. These studies 
showed that, electrostatic force plays an important role for the interaction between 
ionized solutes and phospholipids in the membrane-like systems (Publications 6-7). 
These studies contribute significantly to a better understanding of the partitioning 
mechanisms of drugs in different model membrane systems, and thus make it possible 
on a scientific basis to develop highly predictive artificial membrane systems for drug 
membrane permeation i vivo. 
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1  Drug permeation and lipophilicity 
1.1  Drug diffusion and transport across biological barriers 
Successful drug development requires not only optimization of specific and potent 
pharmacodynamic activity, but also efficient delivry to the target site. To elicit its 
pharmacological and therapeutic effects, a drug has to cross various cellular barriers by 
passive and/or by carrier-mediated uptake. Membrane permeability is a key determinant 
in the effectiveness of pharmacokinetic behaviors (absorption, distribution, metabolism 
and elimination, ADME) of drugs especially absorption and distribution. In recent years, 
the advances in automated synthesis, combinatorial chemistry and innovative high-
throughput screening have led to the production of a vast number of potential drug 
candidates, often making delivery problems the rat -limiting step in drug research [1]. In 
order to overcome this problem, it is necessary to have a detailed picture of the 
structures of pharmacokinetic barriers.  
1.1.1  Structure of cell membranes 
The currently accepted structure of typical membranes is a fluid-like bilayer 
arrangement of phospholipids [2] (Figure 1). The proteins and other substances such as 
steroids and glycolipids are either associated with its surface or embedded in it to 
different degrees. This structure is an intermdiate state between the true liquid and solid 
states, with the lipid and protein molecules having a limited degree of rotational and 
lateral movement [3]. The polar heads of the phospholipids molecules are orientated to 
form an almost continuous polar layer on both the inside and outside of the cell 
membrane. In contrast, the long hydrophobic chains of the phospholipids molecules 
extend into the central core of the membrane. 
The lipid component of the cell membrane of mammals is mainly composed of 
glycerophospholipids, sphingolipids and cholesterol whose structures are shown in 
Figure 2 [4-5]. It can be seen from the struc ures that the lipid molecules are either 
negatively charged or zwitterionic [5-6] (electri ally neutral at all physiological values 
of pH). These lipids are distributed asymmetrically in the inner and outer leaflets in most 
biological membranes. The outer leaflet of the bilayer consists mainly of electrically 
 4
neutral lipids, such as phosphatidylcholine (PC) and phosphatidylethanolamine (PE), 
while the negatively charged lipids such as phosphatidylserine (PS) are located in the 
inner layer [7]. These lipid molecules are held together by weak hydrophobic bonding 
and van der Waals’ forces. 
 
 
Figure 1. The fluid mosaic model of membranes [8]. 
 
The peripheral and integral proteins located in the membranes are responsible for 
carrying out many of the active functions of mebranes, such as acting as receptors and 
transportation routes for various substances across the membranes. The formation of 
pores including ion channels are also associated with integral proteins. 
The neighboring cells are linked to each ot er by a continuous junctional complex 
referred to as tight junction. Itis a region where the outer leaflets of the lipid bilayer 
comprising the membrane of neighboring cells are fused. The interconnected monolayer 
of cells in the intestinal epithelium is the principle permeation barrier for oral absorption 
of drugs. Similarly, a special class of capillary endothelial cells interlinked by 
exceptionally tight junctions constitute the principle barrier for drug transport from 
blood to brain [9].  
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1.1.2  The transfer of drugs through cell membranes 
1.1.2.1 Passive Diffusion 
The process, in which a molecular moves down its concentration gradient 
without the membrane actively participating, is termed passive diffusion. Passive 
diffusion through a biomembrane may occur through its lipid structures ( = 
transcellular pathway, B in Figure 3), and through its water-filled pores or tight 
junctions ( = paracellular pathway, A in Figure 3) [10]. For the vast majority of drugs, 
the transport is mediated by passive transcellular diffusion through the apical cell 
membranes, across the cell proper and across the basolateral membrane [9]. The ease 
of passive transcellular diffusion depends on the ability of the molecular to partition 
into the cell membranes. In order to permeate by this route, a compound must have an 
optimum lipophilicity because if the solute is too lipophilic it will remain trapped in 
the membrane. A measure of lipophilicity can be o tained by the partition coefficients 
in different systems such as n-octanol/water pa titioning system. The predictive value 
of the relations between lipophilicity and membrane permeation depends on the 
relevance of the partitioning systems as models of biomembranes [11]. 
Intestinal absorption via paracellular way is relevant for hydrophilic compounds 
with molecular weights lower than 200 [12]. Since the paracelluar pathway is an 
aqueous extracellular route across the intestinal epithelium, sufficient hydrophilicity is 
the most important prerequisite for a drug to traverse the cell barrier via this pathway 
[13]. In addition, the size and charge of a drug are also the crucial molecular 
characteristics for this route. It is reported that tight junctions are impermeable to 
molecules with radii larger than 10-15 Å [14] and that an optimal net charge is very 
important for the efficient transport through intestinal epithelium via this route [15]. 
In contrast, paracellular absorption is negligible at the BBB due to the occlusive 
network of tight junctions of the brain capillary endothelial cells [16]. 
1.1.2.2 Active transport 
Some hydrophilic drugs whose chemical struc ure mimics various nutrients can 
be transported across the mebranes by carrier-facilitated transport (C in Figure 3). 
This process usually operates against a concentration gradient and is fairly substrate-
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specific. Different carriers and transporters have been described in various types of 
cells. They have been identified mostly as integral membrane proteins [17]. 
Contrary to carrier-facilitated transport, efflux systems (D in Figure 3) present 
in the membranes create a major barrier to the absorption of a wide variety of 
xenobiotics. Although these efflux systems are most commonly observed in tumor 
cells, they are also known to be present in normal intestinal epithelia and BBB [18]. 
These efflux systems are related to P-glycoprotein, the principle component of 
multidrug resistance in a variety of cell types. P-glycoprotein is a 170-180 kDa 
membrane glycoprotein that cts as an ATP-dependent efflux pump, thereby reducing 
the transcellular flux of a wide variety of drugs [19]. 
 
 
Figure 3. Pathways of transport across the intestinal mucosa. A: Passive diffusion via 
paracellular route. B: Passive diffusion via transcellular route. C: Transporter-
facilitated pathway. D: Transport-restricted pathway (e.g., by efflux 
transporters) [20]. 
 
1.1.3  The main physiological barriers 
1.1.3.1 Intestinal epithelium 
Because the majority of the marketed drugs (about 90%) are administered 
orally, the main physiological barrier drugs have to pass to enter the body is the 
intestinal epithelial membrane. The human small intestine membrane has a fractal-like 
structure, i.e., the ridges (oriented circumferentially around the lumen), villi and 
microville [21]. The membrane surface is expanded approximately up to 600-fold by 
the villi and microvilli. Due to this large surface area, the small intestine is the main 
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region of absorption for drugs [22]. The intestinal membrane has the mucus layer on 
the villi, which is thought to maintain the unstirred water layer (UWL). The UWL is 
also considered a significant barrier to the passive diffusion of lipophilic drugs [23]. 
The permeation of drugs across the intestinal epithelial membrane can occur via 
passive transcellular pathway, the paracellular pathway, and active transport, 
depending on the physicochemical properties and structural characteristics of the 
compounds.  
1.1.3.2 Blood-brain barrier (BBB) 
The BBB, which has an estimated surface area of 12 m2 in humans [24], is 
formed by the tight endothelia  cell layer in the brain capillaries and control the 
exchange of drugs, nutrients, hormones, metabolites and immunlogical cells between 
the blood and brain in both directions. BBB endothelium forms a much tighter 
interface than peripheral endothelia. In the periphery most small solutes can diffuse 
between the intercellular clefts of 50-200 nm width [25]. In contrast, the gaps between 
capillary endothelial cells in most part of the brain are tightly sealed by tight junctions 
(which exclude molecules with a diameter la ger than 20Å) and thus have severely 
limited permeability [26]. The paracellular pathway is negligible for most compounds 
under physiological conditions. The passive permeation is mainly restricted to the 
lipophilic compounds which are able to traverse the lipid membranes of the cells [24].  
1.1.3.3 The skin permeation barrier  
The transdermal route has advantages over ther routes for the delivery of drugs 
with systemic activity. These include the eas of use (and withdrawal in the occurance 
of side-effects), avoidance of first-pass metabolism, and improved patient compliance. 
The transdermal permeation rate of most drugs is limited by the stratum corneum (SC) 
[27]. The SC comprises 10-15 layers of flat keratin-filled cells, closely packed in a 
non-polar lipid matrix, mainly composed offree fatty acids (10-15%), cholesterol 
(25%), sterol esters (5%), and ceramides (50%) [28]. Ceramides are categorized into 9 
subgroups (structures shown in Figure 4) [29], whose head groups can form lateral 
intermolecular hydrogen-bonds. The phase behavior of the lammellar lipid is different 
from that of the lipid bilayer mainly composed of phospholipids. The thickness of the 
SC is different in each body part, for example about 15 μm in the abdominal skin and 
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10 μm in the dorsal skin. The primary transport pathway for most drugs passively 
traversing the SC is the intercellular lipid region [30]. 
 
Figure 4. The chemical structures of ceramides. 
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1.2  The influence of lipophilicity on drug transcellular permeation 
The relationship between the physicochemical properties of drugs and the 
pharmacokinetic process has been extensiv ly studied. Some physicochemical 
parameters of drugs, such as lipophilicity, hydrogen-bonding capacity, molecular size 
and polar surface area, have proved useful for predicting passive transfer and 
permeation across biomembranes in ADME, but none has attracted as much interest in 
quantitative structure-permeation relationship (QSPeR) studies a  lipophilicity. 
1.2.1  Lipophilicity from isotropic solvent systems and its relationship with drug 
transcellular permeation 
Lipophilicity is usually expressed by the partition coefficient (log P), a 
molecular parameter which describes the partition equilibrium of a solute molecule 
between water and an immiscible organic solvent. Partition coefficients are obtained 
as the logarithm of the ratio of concentrations at equilibrium: 
organic
aqueous
C
log P = log 
C
 [Eq. 1.1] 
The most commonly used measure of lipophilicity is n-octanol/water partition 
coefficient (log Poct). The effectiveness of log Poct in correlating biological 
properties has been extensively investigated. However, the log Poct scale of 
lipophilicity alone is not effective in modelling the crossing of any kind of cell 
membranes due to the severe differences in their biophysical properties [31-32]. Thus 
four types of isotropic solvent systems (amphiprotic, inert, hydrogen bond donor and 
hydrogen-bond acceptor) called ‘critical quartet’ ( .g., n-octanol/water, alkanes/water, 
chloroform/water and dibutyl ether/water) are necessary in order to cover adequately 
the range of biophysical properties of mebranes [33-34]. The ‘critical quartet’ 
expresses in partly overlapping and partly complementary ways the recognition forces 
that account for membrane partitioning and biological selectivity [35-36]. 
For ionizable drugs, the apparent distribut on coefficient (log D) at pH 7.4 is 
also often used. Unlike log P, which is valid only for a single chemical species, log D 
refers to a pH-dependent mixture of all electrical species present at that pH: 
log DpH = log (fN•PN + fI•PI) [Eq. 1.2] 
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where fN and fI are the molar fractions of the neutral and ionized forms, and PN and PI 
are their respective partition coefficients.  
Lipophilicity is the net result of all intermolecular forces involving a solute and 
the two phases between which it partitions. A highly informative interpretation of 
lipophilicity is based on solvatochromic analysis [37-40] (see also Publications 1-3). 
This method factorizes lipophilicity into a number of parameters: 
• molar volume V (or van der Waal volume Vw) which represents 
hydrophobic and dispersion forces 
• the solute’s H-bond donor acidity (α) and the solute’s H-bond acceptor 
basicity (β) 
• the solute’s dipolarity/polarizability (π*) which accounts for orientation 
and induction forces 
 
For example, the n-octanol/water and heptane/water partition coefficient (log Poct and 
log Phep) can be expressed as [41]: 
oct
2
log P  = 5.83( 0.53) V/100 - 0.74( 0.31) * 
                - 3.51( 0.38)  - 0.15( 0.23)  - 0.02( 0.34)
N = 78; r  = 0.92; s = 0.30; F = 248
± • ± • π
± •β ± •α ±  [Eq. 1.3] 
where N is the number of compounds, r2 the squared correlation coefficient, s the 
standard deviation and F the Fisher’s test. 
hep
2
log P  = 6.78( 0.69) V/100 - 1.02( 0.39) * 
                - 5.35( 0.50)  - 3.54( 0.30)  - 0.06( 0.43)
N = 75; r  = 0.96; s = 0.36; F = 438
± • ± • π
± •β ± •α ±  [Eq. 1.4] 
As a result of such equations, lipophilicity can be factorized into two sets of 
terms, namely hydrophobicity which accounts for hydrophobic and dispersion forces, 
and polar terms which account for hydrogen bonds, and orientation and induction 
forces [42]: 
Lipophilicity = Hydrophobicity - Polarity  [Eq. 1.5] 
Eq. 1.3 shows that V and β are the most important structural descriptors 
contributing to log Poct, while π* is of secondary importance and α has no statistical 
significance in n-octanol/water system. A different partitioning mechanism exists in 
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heptane/water system as shown in Eq. 1.4: V and β are the most important structural 
descriptors contributing to log Phep, while α and π* are of secondary importance. 
Lipophilicity descriptors obtained in different solvent systems can be compared 
to derive a Δlog P when the two log P values do n t contain identical structural 
information [41]. A well-known example is Δlog Poct-alk, the difference between n-
octanol/water and alkane/water partition coefficients [39]. This parameter is 
physicochemically meaningful and express mainly the H-bond donor acidity of 
solutes as shown by Eq. 1.6: 
 
oct-hep
2
log  P  = 3.54( 0.36)  - 0.37( 0.15)
n = 75; r  = 0.84; s = 0.45; F = 325 
± •α ±
 [Eq. 1.6] 
 
To overcome some experimental problems caused by the low alkane solubility 
of many compounds, the 1,2-dichloroethane/water (DCE/water) system was suggested 
to replace the alkane/water system [40]. Therefore, Δlog Poct-dce is now proposed 
instead of Δlog Poct-alk. 
The experimental techniques for lipophilicity measurement in isotropic 
solvent/water systems are shake-flask method [43] and potentiometric titration [44], 
which have been thoroughly described in the literatures. 
In numerous studies on drug permeation through biological membranes (e.g., 
gut wall, skin, blood-brain barrier, and more recently Caco-2 cell monolayers), 
relationships between permeation and lipophilicity have been developed with 
homologous series of compounds of a diverse nature (acidic, alkaline and neutral) to 
explore the influence of lipophilicity on passive diffusion. 
Thus, linear relationships were found betwen absorption rate constants from rat 
stomach and a) partition coefficient in CCl4/water for 16 barbiturates [45], b) partition 
coefficient in n-octanol/water for 11 carbamates [46]. A bilinear correlation was 
found between in situ gastric absorption rate constants determined in rats and 
lipophilicity indices (measured in RP-HPLC) for a series of phenylalkylcarboxylic 
acids [47]. Sigmoidal relationships were established between permeability coefficients 
in Caco-2 cell monolayers and log Doct (pH 7.4) for a set of β-blockers [48] and a 
series of N-acylated derivatives of 5-fluorouracil [49], respectively. The same type of 
relationship between permeability in the rat jejunum and log Poct were also found for 
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7 steroids [50] and 11 β-blockers [51]. Parabolic correlations were found between 
human skin permeability coefficients and log Poct for a homogeneous set of phenols 
[52], between human epidermis permeability coefficients and log Poct for 6 non-
steroidal anti-inflammatory agents [53], and between corneal permeability coefficients 
and log Doct (pH 7.65) for a series of 12 β-blockers [54]. To rationalize the observed 
relationships, different theoretical models for passive membrane diffusion have been 
derived and discussed [10, 55-56]. 
The Δlog Poct-alk parameter, which mainly express H-bond donor acidity, also 
showed its power in the prediction ofdrug permeation. For a series of H2-receptor 
antagonists, brain penetration (logarithm of brain/blood ratios) in the rat was inversely 
correlated with Δlog Poct-cyc parameter (cyc = cyclohexane) [57]. Similar 
correlations were found between permeability coefficients across excised rabbit 
cornea and Δlog Poct-cyc for a set of drugs including β-blockers and steroids [58], 
between oral absorption and Δlog Poct-cyc for a family of azole endothelin 
antagonists [59], and between human skin permeability coefficients and Δlog Poct-
hep for a set of compounds including alcohols and steroids [52]. These examples 
imply that the H-bond donor acidity is very important in drug design to improve the 
pharmacokinetic profile of drugs. 
1.2.2  Lipophilicity from anisotropic biomembrane-like systems and its relationship 
with drug transcellular permeation 
Although partitioning in n-octanol/water system is accepted as an informative 
model of membrane partitioning, log Poct (or log Doct) can not give a good estimate 
of a drug´s absorption or permeation [30-2] in some cases especially for the 
structurally unrelated or ionized compounds. Lipophilicity as a molecular parameter 
encodes different intermolecular forces (Figure 5). When expressed by log P 
measured in isotropic organic solvent/water systems, lipophilicity fails to encode 
some important recognition forces, most notably ionic bonds, which are of particular 
importance when modeling the interaction f ionized compounds with biomembranes 
[41]. Because the majority of the drugs are ionizable [60], any prediction of their 
pharmacodynamic and pharmacokinetic properties should take their ionization into 
account. In anisotropic membrane-like systems such as liposome/water partitioning 
system, lipophilicity can be expressed as:  
 14
Lipophilicity = Hydrophobicity – Polarity + Ionic Interactions  [Eq. 1.7] 
Liposomes have been used for several decades as model membranes to study 
solute/biological membranes interactions. The partitioning behavior of solutes 
between liposomal membranes and aqueous phases provides information on their 
affinity to biological membranes and on their in vivo pharmacokinetic behavior in 
general. The liposomes/water partitioning system is increasingly employed as an 
alternative to n-octanol/water for the estimation of pharmacokinetic behavior of drugs 
[61]. 
 
Figure 5.   A comparison between the intermolecular forces that govern molecular 
recognition in biochemical and pharmacological processes, and those expressed in 
lipophilicity [41]. 
 
Liposomes can be prepared from a variety of lipids and mixtures of them. 
Phospholipids are frequently used to obtain standardized and easily reproducible 
systems [62]. Liposomes have a spherical shpe and are composed of one to several 
hundred concentric bilayers. The sizes range from 20 nm to several dozens 
micrometers, whereas the thickness of the bilayer membrane is approximately 4-7 nm 
[5]. Depending on the number of bilayer sheets, liposomes can be distinguished 
between large multilamellar vesicles (LMV’s), large unilamellar vesicles (LUV’s) and 
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small unilamellar vesicles (SUV’s, diameter smaller than 100 nm). Liposomes in 
partition studies are ideally unilamellar, which have a reproducible size distribution.  
Liposomes of various compositions have been shown to provide better 
correlations of pharmacokinetic behavior, as well as biological activities of certain 
classes of drugs than the n-octanol/water system [63-66]. Here are the examples to 
name a few. 
For a series of nine nitroimidazole drugs, liposomal partitioning system 
(LMV’s) composed of L-α-Dimyristoylphosphatidylcholine (DMPC) provided a 
much better prediction of plasma clearance rate than n-octanol/water partitioning 
system [64]. For a set of structurally diversed ionisable compounds, the 
phosphatidylcholine liposomes (SUV’s)/saline revealed a better correlation between 
passive intestinal absorption in humans and  so called absorption potential (AP) than 
n-octanol/water partition system. The AP is calculated from log D at pH 6.8 (pH of 
the fasted small intestine), solubility, mean single oral dose, and intestinal fluid 
volumes [65]. For a set of 10 imidazolidines, liposomal partitioning systems 
composed of DMPC or DMPC/CHOL(chlosterol)/DCP (dicetylphosphate) showed 
advantages than n-octanol/water to predict α2-adrenergic potencies [66]. 
The most popular methods to investiga e lipophilicity in liposome/water 
systems are potentiometric titration [67] and equilibrium dialysis [68]. However these 
two methods are very labor-consuming. In recent years, high-throughput 
chromatographic techniques, including immobilized artificial membrane (IAM) 
HPLC-columns [69], immobilized liposome chromatography [70], and liposome (or 
microemulsion) electrokinetic chromatography [71] have been developed for the 
determination of drug partitioning into biomembranes. These methods are discussed 
in detail in Chapter 2. 
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2 Chromatographic approaches to assess drug partition into 
biomembranes 
As discussed in Chapter 1, log P from n-octanol/water (log Poct) and 
liposome/water partitioning systems is a widely used measure of lipophilicity to predict 
pharmacokinetic behaviors of drugs. For many years, the conventional procedures to 
measure log P is a shake-flask method [1], potentiometric titration [2] and equilibrium 
dialysis [3]. However, these methods are time-consuming and not suitable for the high-
throughput screening in modern drug discovery. In order to overcome the disadvantages 
of these techniques, the chromatographic approaches have been introduced to measure 
drug partition into biomembranes. 
 
2.1  Reversed phase HPLC (RP-HPLC) method 
The low throughput and resource intensity of the traditional shake-flask method 
for measurement of log Poct resulted in the investigation of reversed-phase HPLC 
chromatography as a surrogate [4-12]. Test compounds partition between the mobile 
phase and the lipophilic HPLC stationary phase. The degree of partitioning is measured 
by the analyte’s retention express d by retention factor, which is either isocratic capacity 
factor (Eq. 2.1) or the capacity factor extrapolated to 100 % water (log kw) (Eq. 2.2). 
r 0
0
t  - tlog k  log 
t
=  [Eq. 2.1] 
wklog   S-  klog +ϕ=  [Eq. 2.2] 
If the proper stationary and mobile phases are chosen, the log k (or log kw) values 
are correlated with the log Poct values as shown by equation 2.3:  
log Poct = a log k (log kw) + b [Eq. 2.3] 
From this equation, the log Poct value of a previously unmeasured compound can be 
estimated. Many investigators have used log kw as the RP-HPLC measured lipophilicity 
parameter to eliminate organic solvent effects [6-7, 13-16]. On the other hand, other 
reporters use isocratic log k values at an appropriate methanol concentration [4, 17-19]. 
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Extensive studies have been done to find optimal stationary and mobile phase 
conditions in order to obtain log kw or log k values best correlated with log Poct values. 
Several types of stationary phases such as silica-based columns and polymer-based 
columns have been investigated. In the early stage of this method, the most frequently 
used are octadecylsilane (ODS) stationary phases. Generally, the correlations between 
log kw or log k obtained on this kind of columns and log Poct are good only as long as 
the solutes analyzed are structurally related (congeneric) [20-21]. It was supposed that 
the decrease in correlation between capacity factors and log Poct with an increasing 
structural diversity of solutes results mainly from specific interactions of the compounds 
with residual silanol groups on this kind of stationary phase [22].  
Much has been done to decrease the effects of free silanol groups. A masking 
agent (n-decylamine) was proposed to be added to the mobile phase [23-24]. Great 
progress has been achieved in silica-based stationary phases exhibiting high level of 
silanol deactivation, among which LC-ABZ, ABZ+Plus and DiscoveryTM RP Amide 
C16 (Supelco, Bellefonte, PA, USA) are good examples. In these stationary phases, the 
alkyl chains contain an amide group which electrostatically shields silanols from highly 
polar analytes. In addition, it is hypothesized that the combination of amide groups and a 
hydration layer at the silica surface leads to a high degree of orientation of the alkyl 
chains of the stationary phase. This avoids blocking the solute from reaching the surface 
as happens in the conventional C18 RP-HPLC stationary phase due to the folding of the 
alkyl chains [25]. Log kw values measured on these three columns gave good 
correlations with log Poct values for a set of monofunctional compounds which cover a 
broad property space as shown in [26-27]. By using a mobile phase enriched in 1-
octanol, highly significant correlations were also built between log Poct and log kw 
values obtained on LC-ABZ [15-16] and on DiscoveryTM RP Amide C16 [28-29] for a 
set of noncongeneric complex drugs. 
In spite of the improvement in silanol deactivation of silica-based stationary 
phases, one big disadvantage of this type of stationary phases is their chemical 
instability at pH above 8 and below 2. In case of majority of organic bases, lipophilicity 
can not be determined directly for neutral forms.  
Polymer-based stationary phases are devoid of reactive silanol groups and 
chemically stable over a wide pH range. Poly(styrene-divinylbenzene) copolymers (PS-
DVB) have been studied and reported to provide rather moderate correlations with log 
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Poct [30]. Instead, they were found to mimic alkane/water partition [31]. The restrictions 
of PS-DVB columns are that they are characterized by low efficiency and the material 
suffers from excessive shrinkage and swelling [30]. 
Octadecyl polyvinyl copolymer (ODP) does not undergo swelling nor shrinkage 
and offers the possibility of having reasonable flow rate without undesirable pressure 
increase at the column inlet [30, 32]. Moreover, it has the advantage that one can 
measure log kw values directly, i.e., at 100% water as mobile phase. For a set of 
monofunctional compounds, correlations between log kw obtained on this type of 
columns and log Poct are as good as obtained with the ODS stationary phase [30, 33]. 
However, by using a wide range of noncongeeric compounds including complex drugs, 
ODP stationary phase yielded a lipophilicity index log kw significantly lower correlated 
with log Poct than that obtained with DiscoveryTM RP Amide C16 phase [29].  
Recently, a novel type of RP-HPLC stationary phase such as XbridgeTM Shield 
RP18 produced by BEH Technology has become available [34]. This support is a hybrid 
stationary phase with ethylene bridges inside th  silica matrix. It affords a wide pH 
resistance (1-12) to silica-based materials that has the same alkyl chains as those in LC-
ABZ and DiscoveryTM RP Amide C16, and thus make it possible to measure 
lipophilicity not only for neutral and acidic compounds, but also for basic ones. The 
lipophilicity index log kw obtained with this stationary phase is highly correlated with 
log Poct values for a wide range of structurally diversed neutral, acidic, ampholytic and 
basic solutes including complex drugs [35]. By using a same type of column (Acquity 
BEH Shield RP18), it was shown that isocratic log k at 50% methanol could give a 
precise prediction of log Poct values for basic compounds [36]. The results of these 
studies are of potential interest for the high-throughput screening of lipophilicity in drug 
discovery, where basic compounds predominate. 
On most lipophilic HPLC stationary phases, pure water (or aqueous buffer) cannot 
be used as mobile phase. Therefore, mainly binary mixtures of water (or aqueous buffer) 
with an organic modifier are used. Methanol is by far the most commonly used organic 
modifier in the determination of partition coefficients [7, 18, 20]. There are several 
reasons for this. First, methanol is the most water-like of all commonly used RP-HPLC 
solvents including also acetonitrile and tetrahydrofuran. Itis capable of hydrogen bond 
acceptance and donation and thus can easily be incorporated in the network of water 
molecules [8]. Not only the mobile phase, but also the stationary phase, are affected less 
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with methanol. It has been shown that the adsorption of acetonitrile and tetrahydrofuran 
to alkyl-bonded silica occurs to a great r degree than with methanol [37].  
The second reason to use methanol is that it generally has significantly less 
curvature than either tetrahydrofuran or acetonitrile in plots of log k versus volume 
fraction of organic modifier ϕ [8, 38]. Thus, the errors are minimized in extrapolations 
to obtain log kw. 
Phosphate buffers and zwitterionic buffers (such as morpholinopropane sulfonic 
acid) are often used to adjust the pH of the mobile phase. However, zwitterionic buffers 
are preferred for charged basic compounds since phosphate buffers are likely to form 
ion-pairs with them. 
For charged organic compounds, it is often tempting to buffer the mobile phase at 
the pH of interest. For example, pH 7.4 is often used for pharmaceutical applications 
since this is the physiological pH. However, there are several problems with this 
approach. First, the pH is only an apparent pH since the mobile phase is not entirely 
made of water. Second, ionization constants (pKa) will be affected by the organic 
modifiers. Thus, it is preferable to buffer the mobile phase in order to ensure that the 
compound is in its neutral form (if possible), yielding intrinsic log kw [18]. The log kw 
at a particular pH (log kwapp) can then be calculated by the following equations: 
For monoprotic acids: 
apH-pKappw wlog k  = log k  - log (1 + 10 )  [Eq. 2.4] 
For monoprotic bases: 
apK -pHappw wlog k  = log k  - log (1 + 10 )  [Eq. 2.5]  
 
2.2  Immobilized artificial membrane (IAM) chromatography 
The main reason to use the chromatographic system to determine lipophilicity is to 
conveniently model drug transport processes across biological membranes. Hence, the 
components of the chromatographic and the biological systems should be comparable. A 
HPLC system which is used to model transport of a drug through biological membranes 
should be composed of an aqueous phase nd an organized phospholipids layer. 
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Immobilized artificial membranes (IAMs) consist of monolayers of phospholipids 
covalently immobilized to silica surface, thus mimicking the lipid environment of a fluid 
cell membrane on a solid matrix [39-40]. The structures of the commercially available 
immobilized artificial membranes are shown in Figure 1. 
 
Figure 1. Structures of the commercially available immobilized artificial membranes. 
 
The lipophilicity index from IAM chromatography is the capacity factor log 
kIAMw  at 100 % aqueous phase. For hydrophilic compounds, log kIAMw  can be 
determined directly by using the aqueous mobile phase. For lipophilic drugs, it is 
necessary to add organic modifier (methanol or acetonitrile) to the mobile phase to 
accelerate the elution. The log kIAMw  value is then extrapolated from isocratic capacity 
factors using Eq. 2.2. No significant difference was observed for the linear extrapolation 
when using either methanol or acetonitrile. However, methanol is more appropriate 
when charged compounds are chromatographed [41]. Furthermore, when acetonitrile is 
used, mobile phases containing more than 30% (w/w) must be avoided because their 
microheterogeneity disrupts the structure of water [42]. It was reported the 
chromatography on IAM stationary phase is deteriorating after 3 months of use [43], 
thus measures should be taken to check the decrease of the capacity factor over time. 
The interaction of drugs with phospholipids has been investigated by IAM-HPLC 
for different sets of neutral and charged compounds such as β-blockers [44], non-
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steroidal anti-inflammatory drugs (NSAIDs) [45], dihydropyridine (DHPs) calcium 
channel blockers [46], and for a set of compounds with a wide structural diversity [47]. 
It was found that log kIAMw  values from IAM columns correlate with log Poct only for 
neutral and structurally related compounds, and that electrostatic interaction between the 
charged solutes and the polar heads of phospholipid play a vital role in IAMs.  
The relationship between IAM retention and partitioning in egg 
phosphatidylcholine (EPC) liposome/water was also studied [48]. No correlation existed 
between log kIAMw
7.0 and log D7.0 in EPC liposome/water for noncongeneous set of 
compounds. One possible reason for the difference between the lipophilicity indice from 
these two anisotropic systems is the different density of the polar phospholipid head-
groups, which were proved an important factor for drug partitioning in biological and 
artificial membranes [49]. 
The log kIAMw  determined on IAM columns appears to be a better predictor of 
bioactivity than log Poct for drugs of different chemical nature. The log kIAMw  values 
obtained on this type of columns were reported to be well correlated with human skin 
permeation for a set of steroids and phenols [50]. The oral absorption of cephalosporin 
prodrugs in mice could be better predicted by log kIAMw  than by analogous parameters 
determined on traditional ODS reversed phases [49]. The log kIAMw
7.0 (measured at pH 
7.0) values of 12 structurally diverse compounds were determined on an IAM.PC.DD2 
phase, and their permeabilities (Pa) were measured through rat everted gut sacs for 
passively diffused compounds or through noneverted sacs for actively transported 
molecules. The log kIAMw
7.0 correlated with Pa better than log Poct. The addition of 
molar volume (Vx) as a second independent variable slightly improved the correlation 
[51]. For a series of (NSAIDs), a parabolic relationship was obtained between log 
kIAMw and the capacity of diffusion across the rat blood-brain barier (BBB) [52], 
suggesting an optimum lipophilicity of drugs in the transport to brain. 
 
2.3  Immobilized liposome chromatography (ILC) 
ILC was a simple and fast tool for analysis of solute-membrane interactions. In 
ILC, phospholipid-based liposomes are noncovalently immobilized to gel beads (e.g., 
Superdex 200) as a stationary phase of chromatography [53]. The main advantages of 
this method are that phases of different chemical composition can be easily and 
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reversibly immobilized on suitable gel supports. Phosphatidylcholine (PC), mixtures of 
PC/PS (phosphatidylserine) and PC/PE (phosphatidylethanolamine), egg 
phosphatidylcholine (EPC), lipids extracted from human red cells have been used for 
ILC [54-55]. In addition, chromatographic retention on phospholipids is devoid of any 
effect caused by the presence of a silica matrix. 
Various techniques have been developed for immobilization of liposomes. In some 
studies, liposomes are mixed with dry gel b ads and immobilized by gel bead swelling 
followed by freezing-thawing to induce liposome fusion [53-55]. During the freezing-
thawing process, the liposomes grow in size and are entrapped in the gel beads pore. The 
immobilized liposome has a multiamellar structure [56]. The multiamellar structure 
would not affect the partitioning of the majority of amphiphilic drugs because they pass 
the bilayers fast enough during the chromatographic run [54]. In other studies, 
unilamellar liposomes are immobilized in the g l pores of gel beads by avidin-biotin 
binding [57-58]. The liposome immobilized gel is packed into a column. The capacity 
factor of the drugs log Ks (Eq. 2.6.) is measured by HPLC using an aqueous buffer 
eluent as the lipophilicity index.  
log Ks = log [(VR - V0) / A] [Eq. 2.6] 
where VR and V0 are the retention volumes of the drug and of an unretained compound, 
and A is the amount of the immobilized phospholipids.  
No significant correlation was found between log Ks and log D from 
liposome/water partitioning system, log kIAMw  or log Doct for structurally unrelated 
compounds [54, 59]. 
A hyperbolic relationship between oral absorption in human and log Ks from EPC 
liposomes was established for a set of 12 structu ally unrelated drugs [53]. In another 
study by the same group, it was further observed that drugs with log Ks values (from 
human red blood extract) between 1.5 and 2.5 are nearly 100% absorbed [55], the results 
showed that the essential feature of a good biomembrane model for drug partitioning 
analyses is a bilayer heterogeneity mimicking that of natural membranes. A sigmoidal 
relationship was found between log Ks values from EPC-PS-PE-Chol (cholesterol) and 
intestinal absorption for a set of 29 structurally diverse drugs [58]. 
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2.4  Liposome electrokinetic chromatography (LEKC) 
LEKC is a capillary electrophoresis method where liposomes are incorporated in 
the buffer as a pseudostationary phase for the determination of drug-membrane 
interactions [60-61]. In LEKC, the composition of the lipid bilayer pseudo phase can be 
carefully controlled to nearly mimic the properties of the natural membranes through 
adjustment of the type and mole fractions of phospholipids as well as incorporating 
“additives” such as cholesterol and even proteins.  
Figure 2 illustrates the mechanism of the migration and separation of two 
uncharged solutes, S1 and S2 in LEKC based on negatively charged liposomes. The 
electrophoretic migration of the liposomes is toward the anode; but the stronger 
electroosmotic flow carries the liposomes and the solutes toward the cathode where they 
are detected. Neutral solutes are separated according to their differences in 
liposome/water partition. 
 
Figure 2. Schematic of the migration pattern in LEKC with a negatively charged 
liposome. S1 and S2 represent two solutes that partition into the liposome. μLip and μEOF are 
the mobilities of a liposome and the ElectroOsmotic Flow (EOF), respectively. Finally, teo, 
tr1, tr2, and tlip are the retention times of the unretained marker (methanol), two solutes, and 
liposome marker (n-decanophenone), respectively [60]. 
 
The retention factor log k of neutral solutes, as the lipophilicity index from LEKC 
is calculated by Eq. 2.7, where tR, eo, and tpsp are the retention times of the solute, 
methanol and the marker of the pseudostationary phases (n-decanophenone), 
respectively. Charged solutes will posess their own electrophoretic mobility in the 
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aqueous phase in addition to partitioning into the liposomes and migrating at the 
liposome mobility. As a result, the migration of solutes in the bulk aqueous (t0) needs to 
be included in the calculation of reten ion factor as shown in Eq. 2.8 [62]. 
log k = log [(tR – teo)/teo (1 - tR/tpsp)] [Eq. 2.7] 
log k = log [(tR – t0)/t0 (1 - tR/tpsp)] [Eq. 2.8] 
There are significant advantages in using LEKC for assessment of drug-membrane 
interaction over the existing models such as n-octanol/water, IAM or ILC. Liposomes 
are spherical lipid bilayer microstructures that are made of phospholipids and closely 
resemble biologic cell membranes, thus they are more suitable models for the dynamic 
and fluid lipid bilayer environment of cell membranes than other models. Also, using 
LEKC, it is possible to establish universal and consistent lipophilicity scales for drug-
membranes interaction studies for interlaborat y use. On the contrary, RP-HPLC and 
IAM method lack a universal scale due to the difference of HPLC columns. 
Unilamellar liposomes with a narrow size distribution are most often used as 
pseudostationary phases. For multilamellar liposomes, the size can range from 
approximately 100 nm to 1 μm due to large number of bilayers. They are not suitable as 
carriers in LEKC because the background in the electropherogram was very noisy and 
the sensitivity was low [63]. 
For nonhomogenous drugs of different chemical natures, the following 
correlations were found: a good correlation was built between the log k values from 
LEKC based on POPC-PS liposomes and caco-2 ell monolayer permeability [64]; A 
sigmoidal relationship was found between log k values from LEKC based on EPC-PS 
liposomes and human intestinal drug absorption, where log Poct could not show a good 
predicting power [65]; log k from LEKC using PC-PS liposomes gave the better 
correlation with drug penetration across BBB than log Doct7.4, Clog P, PSA [66]. 
Recently it was proved that LEKC is a promising method to predict drug penetration 
through the skin. Quantitative retention-activity relationships (QRARs) were 
successfully constructed between the compound skin permeability coefficient (log Kp) 
and the retention values (log k), as well as some calculated molecular descriptors by the 
stepwise regression method (R2 = 0.902) [67]. 
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As a summary, the major advantage of the chromatographic methods is its good 
throughput. Second, only small amounts of comp unds are needed, typically in the order 
of 1 mg. Third, the methods are generally insensitive to impurities or degradation 
products which might affect bulk partitioning or analysis.  
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Lipophilicity Measurement by Reversed-Phase High-Performance Liquid
Chromatography (RP-HPLC): A Comparison of Two Stationary Phases
Based on Retention Mechanisms
by Xiangli Liu*a), Hideji Tanakaa), Aiko Yamauchia), Bernard Testab), and Hiroshi Chumana)
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The mechanisms of retention of two recent stationary phases of interest in lipophilicity measurements,
namely of the silica-based Discovery-RP-Amide-C16 phase and the polymer-based ODP-50-4B phase, were
assessed and compared. A set of 41 model solutes and drugs with well-defined solvatochromic parameters were
selected to allow a broad distribution of property spaces. The chromatographic results showed that, under the
conditions of study, the lipophilicity index log kw obtained with the former stationary phase was more closely
related to experimental log Poct values than was log kw obtained with the ODP-50-4B phase. Linear solvation/
free-energy relationship (LSER) analyses showed that the retention mechanisms of the two stationary phases
are different, retention on the Discovery-RP-Amide-C16 phase and partitioning in octan-1-ol/H2O being
controlled by the same balance of intermolecular forces (Van der Waals volume Vw, H-bond acceptor basicity ,
and dipolarity/polarizability *).
Introduction. ± The lipophilicity of solutes, traditionally expressed by their partition
coefficients in the octan-1-ol/H2O system (noted log Poct), is of high significance from
both a physicochemical and a pharmacological viewpoint [1] [2]. The partitioning
process expresses the combined effects of a number of intermolecular forces between a
solute and its environment, here the solvents between which the solute partitions.
These intermolecular forces are of particular importance in pharmacology since they
also control the partitioning of solutes into biomembranes. Numerous studies have
reported a relationship between log Poct and absorption or permeability in cell cultures
and tissue preparations used as models of, e.g., the gastrointestinal tract or the blood-
brain barrier [3 ± 7].
The reference procedure to measure log Poct is the shake-flask method which,
however, is time-consuming and limited in range (ca.  3 log P 4). Beyond these
limits, log Poct values measured by the shake-flask method become unreliable.
The reversed-phase HPLC method is a promising alternative to the shake-flask
method, having such advantages as a higher throughput, an insensitivity to impurities or
degradation products, and a broader lipophilicity range. In reversed-phase HPLC,
lipophilicity indices are derived from the capacity factor log k, which is calculated by
Eqn. 1, where tR and t0 are the retention times of the solute and of an unretained
compound, respectively. Some workers have used isocratic log k values measured in an
appropriate mobile phase as a lipophilicity parameter [8 ± 10]. However, many more
investigators use capacity factors extrapolated to 100% H2O (log kw) to eliminate
organic-solvent effects [11 ± 15], and they have indeed demonstrated the usefulness of
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the log kw parameter when investigating series of solutes covering a broad lipophilicity
range. Generally, the extrapolation to 100% H2O is based on a quadratic relationship
between the isocratic capacity factor log k and the volume fraction of organic solvent in
the mobile phase,  [16]. When MeOH is used as the organic modifier, a linear
relationship, Eqn. 2, is often obtained for neutral solutes [17] [18], where S is the slope
and log kw the intercept of the regression curve.
k (tR t0)/t0 (1)
log kS log kw (2)
Until recently, most lipophilicity studies were based on reversed-phase HPLC
octadecyl silica (ODS) stationary phases. The correlations between log Poct and log kw
or log k so obtained are good mostly for structurally related solutes [19] [20]. The
decrease in correlation between capacity factors and log Poct with increasing structural
diversity of solutes is believed to result from specific interactions of the compounds
with the residual silanol groups in such stationary phases [21].
Measures have been taken to decrease the effects of free silanol groups. A masking
agent such as decylamine was added to the mobile phase [22] [23]. Great progress has
been achieved with silica-based stationary phases exhibiting a high level of silanol
deactivation, of which the Discovery-RP-Amide-C16 phase is a good example. In this
stationary phase, the alkyl chains contain an amide group that electrostatically shields
silanols from highly polar analytes.
The polymer-based octadecylpolyvinyl (ODP) stationary phase is devoid of
reactive silanol groups and is regarded as promising for assessing lipophilicity. Unlike
other polymer-based stationary phases, it does not undergo swelling or shrinkage and
offers the possibility of having reasonable flow rates without undesirable pressure
increases at the column inlet [24 ± 26].
A highly informative interpretation of retention mechanisms on reversed-phase
HPLC stationary phases can be obtained by linear solvation/free-energy relationships
(LSERs) based on the solvatochromic parameters [27 ± 32]. This method has also been
used to evaluate partitioning mechanisms of solutes in various organic/aqueous
biphasic systems [33 ± 36]. LSERs can be expressed by Eqn. 3, where Sp is a given
molecular property of a neutral organic solute, here log kw or log Poct . The four
structural parameters are the Van der Waals volume Vw, which accounts for hydro-
phobic and dispersive forces, and polar terms known as solvatochromic parameters
(dipolarity/polarizability *, H-bond donor acidity , and H-bond acceptor basicity ),
which account for polar interactions between solute and solvents. The regression
coefficients v, p, a, and b reflect the relative contribution of each solute parameter to Sp.
Sp v ¥Vwp ¥* a ¥ b ¥  c (3)
The objective of this study was to assess and compare lipophilicity values measured
with the silica-based Discovery-RP-Amide-C16 and the polymer-based ODP-50-4B
stationary phases. A set of solutes with well-defined structural parameters (Vw, *, ,
and ) were selected (Table 1). This set of solutes included simple monofunctional
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Table 1. Investigated Solutes a) and Their Physicochemical Parameters
Discovery RP
Amide C16
ODP-50-4B
Vw
b)c) * b)d)  b)e)  b)f) log Poct b) log kw g) S h) log kw i) S j)
Model solutes
Bases:
Acridine 174.9 1.57 0.52 0.00 3.40 2.74 4.40 3.29 4.00
PhNH2 98.0 0.94 0.41 0.06 0.90 0.11 0.96 1.41 2.04
PhNHEt 133.0 0.78 0.45 0.03 2.16 1.52 2.70 2.46 3.00
2-Cl-C6H4-NH2 111.8 1.06 0.41 0.06 1.91 1.48 2.80 2.55 3.00
2-NH2-C6H4-Ph 173.9 1.55 0.41 0.18 2.84 2.53 4.00 3.49 3.90
Neutrals:
PhCH2CN 121.5 1.22 0.45 0.00 1.56 1.16 2.70 2.28 2.90
PhCOMe 122.3 1.12 0.51 0.00 1.58 1.11 2.50 1.91 2.60
MeCOOBu 123.0 0.55 0.45 0.00 1.82 1.33 2.50 2.10 3.20
PhNO2 107.6 1.01 0.28 0.00 1.85 1.50 2.80 2.51 2.90
2-Cl-C6H4-NO2 122.0 1.13 0.28 0.00 2.24 2.10 3.50 3.04 3.50
Ph(CH2)2Ph 196.9 0.99 0.20 0.00 4.80 4.27 5.40 4.70 4.90
PhCH2OH 111.6 0.84 0.58 0.33 1.08 0.70 2.10 1.37 2.50
4-Cl-C6H4-CH2OH 126.3 0.96 0.58 0.33 1.96 1.62 3.00 2.10 3.00
Acids:
3-Cl-C6H4-OH 107.8 0.84 0.16 0.69 2.49 2.36 3.80 2.88 3.60
3-NO2-C6H4-OH 112.9 1.54 0.23 0.79 2.00 1.75 3.10 2.78 3.50
Ph(CH2)2COOH 146.0 1.12 0.45 0.60 1.89 1.59 2.90 2.18 3.10
Ph(CH2)3COOH 162.4 1.12 0.45 0.60 2.42 2.08 3.40 2.64 3.60
Ph(CH2)4COOH 179.8 1.12 0.45 0.60 2.85 2.53 3.80 3.06 4.00
Ph(CH2)7COOH 230.6 1.12 0.45 0.60 4.09 4.43 5.80 4.34 5.10
C9H19COOH 188.7 0.55 0.45 0.60 4.09 4.37 5.70 3.99 4.90
PhCOOH 111.8 0.74 0.40 0.59 1.96 1.50 3.00 1.83 2.70
4-Br-C6H4-COOH 133.8 0.94 0.40 0.59 2.86 2.48 3.70 2.94 3.60
3-Cl-C6H4-COOH 126.2 0.86 0.30 0.59 2.71 2.29 3.50 2.75 3.50
4-Cl-C6H4-COOH 126.5 0.86 0.27 0.59 2.06 2.28 3.50 2.76 3.50
4-I-C6H4-COOH 141.6 0.96 0.42 0.59 3.13 2.51 3.60 2.92 3.40
1-Naphthoic acid 158.5 1.05 0.40 0.59 3.10 2.47 3.80 2.95 3.50
Drugs:
Flurbiprofen 223.1 1.78 0.49 0.60 3.81 3.54 4.90 3.93 4.60
Ibuprofen 197.0 1.14 0.49 0.60 3.87 3.62 4.90 3.84 4.80
Indomethacin 283.5 1.86 1.29 0.60 3.18 3.67 5.00 4.41 4.70
Ketoprofen 239.1 2.12 0.99 0.60 2.77 2.54 4.00 3.23 4.10
Naproxen 216.5 1.64 0.79 0.60 3.06 2.72 4.10 3.39 4.00
Phenobarbital 204.5 0.59 1.26 0.20 1.44 0.96 2.40 2.04 3.00
Phenytoin 228.3 1.45 1.02 0.60 2.68 1.83 3.40 2.87 4.00
Sulfabenzamide 233.6 2.48 1.25 0.33 1.46 0.88 2.40 2.62 3.60
Sulfacetamide 174.8 2.58 1.25 0.33 ±0.16 ±0.66 0.93 0.54 1.45
Sulfamethazine 237.5 2.72 1.90 0.33 0.25 ±0.32 1.34 0.76 1.40
Sulfamethizole 211.7 2.25 1.46 0.36 0.55 0.07 1.85 1.37 2.20
Sulfamethoxazole 207.5 2.59 1.64 0.36 0.72 0.30 1.78 2.04 2.85
Sulfamethoxypyridazine 229.6 2.93 2.38 0.33 0.35 ±0.18 1.40 1.17 1.80
Sulfanilamide 139.1 1.89 1.26 0.60 ±0.69 ±1.30 0.00 0.47 1.25
Sulfapyridine 209.4 2.76 1.78 0.33 0.02 ±0.33 2.04 0.81 1.50
a) The structures of the complex compounds are shown in Fig. 1. b) Taken from [36]. c) Van der Waals volume.
d) Dipolarity/polarizability. e) H-Bond acceptor basicity. f) H-Bond donor acidity. g) 0.01 s.d. 0.15.
h) 0.01 s.d. 0.29. i) 0.01 s.d. 0.26. j) 0.01 s.d. 0.35.
compounds and complex drugs (Fig. 1) covering a broad range of structural parameters
(Fig. 2) and log Poct values. The relationship between log kw and log Poct , as well as the
relationship between log kw and the slope S, were investigated. The LSERs approach
was applied to unravel the retention mechanisms of the solutes on the two stationary
phases and to compare them with the partitioning mechanism in octan-1-ol/H2O.
Results and Discussion. ± Relationship between log k and . With both the
Discovery-RP-Amide-C16 and ODP-50-4B phases, a linear relationship between log k
and  was found for all compounds. In all cases, the squared correlation coefficient was
higher than 0.99, except for aniline and sulfapyridine (r2 0.98) on the Discovery-RP-
Amide-C16 phase and sulfamethazine (r2 0.98) on the ODP-50-4B phase. The log kw
and S values of the 41 compounds on both phases were calculated by Eqn. 2 and are
presented in Table 1.
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Fig. 1. Structures of the drugs under study
Correlation between log kw and Slope S. The correlations between log kw and slope S
are described by Eqns. 4 and 5 and are shown in Fig. 3, i.e. by Eqn. 4 for theDiscovery-
RP-Amide-C16 phase and by Eqn. 5 for the ODP-50-4B phase.
S 0.94 (0.05) log kw 1.50 (0.11) (4)
n 41, q2 0.97, r2 0.97, s 0.22, F 1407
S 0.93 (0.07) log kw 0.90 (0.18) (5)
n 41, q2 0.95, r2 0.96, s 0.21, F 839
In these and the following equations, 95% confidence limits are in parentheses, n is
the number of the compounds, q2 the cross-validated correlation coefficient, r2 the
squared correlation coefficient, s the standard deviation, and F the Fisher×s test.
The linear correlations between log kw and S are significant for both phases and for
the complete set of compounds. The correlation is slightly better for theDiscovery-RP-
Amide-C16 than for theODP-50-4B phase. However, and as shown in Fig. 3a, there are
two outliers on the Discovery-RP-Amide-C16 phase, namely sulfapyridine and aniline
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Fig. 2. Distribution of the investigated compounds in the parameter space of the Van der Waals volume Vw,
dipolarity/polarizability *, H-bond acceptor basicity  and the H-bond donor acidity 
probably due to the lower quality of the linear regression between log k vs. . After
omission of the two outliers, the correlation between log kw and S becomes excellent
(r2 0.99).
In previous studies, good correlations between log kw and S were obtained only for
simple or closely related compounds [13] [16] [17]. Here, significant correlations were
obtained for a structurally diverse set of analytes including model compounds and
drugs. These significant correlations imply that log kw and S are controlled by the same
factors under the present conditions. In agreement with previous results [20], the slope
of the correlation between log kw and S is nearly 1 on each of the two stationary phases.
Correlation between log Poct and log kw. . Eqns. 6 and 7 and Fig. 4 show the
correlations between log Poct and log kw values, i.e., Eqn. 6 for the Discovery-RP-
Amide-C16 phase and Eqn. 7 for the ODP-50-4B phase.
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Fig. 3. Relationship between log kw and slope S: a) on the Discovery-RP-Amide-C16 phase and b) on theODP-
50-4B phase
log Poct 0.89 (0.06) log kw 0.56 (0.12) (6)
n 41, q2 0.96, r2  0.96, s 0.24, F 1054
log Poct 1.14 (0.12) log kw 0.80 (0.32) (7)
They clearly show that log kw obtained with the Discovery-RP-Amide-C16 phase is
better correlated with log Poct than log kw obtained with theODP-50-4B phase. In other
words, there is a greater similarity between the partitioning mechanism in octan-1-ol/
H2O and the chromatographic retention mechanism on the Discovery-RP-Amide-C16
phase than on the ODP-50-4B phase. This is probably due to the polar amido groups
embedded in the former phase. Also, the throughput of the Discovery-RP-Amide-C16
Fig. 4. Relationship between log Poct and log kw: a) on the Discovery-RP-Amide-C16 phase and b) on the ODP-
50-4B phase
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phase to derive log kw is higher than that of the ODP-50-4B phase due to a more-
limited flow rate of the latter and its larger lipophilicity scale.
The correlation between log Poct and S was found to be of lower quality than that
between log Poct and log kw, implying that the log kw parameter is better suited than S
for log Poct approximations by reversed-phase HPLC.
We conclude from the above results that the silica-basedDiscovery-RP-Amide-C16
phase is a better choice than the polymer-based ODP-50-4B phase to derive a
lipophilicity index (log kw) correlated with log Poct under the mobile-phase conditions
used here.
Comparison between Retention Mechanisms on the Two Stationary Phases and
Partitioning Mechanism in Octan-1-ol/H2O by LSERs Analysis. The log kw values
obtained with the two stationary phases were analyzed by linear solvation/free-energy
relationships (LSERs), yielding statistically significant equations describing the
structural properties governing retention mechanisms, i.e. for the Discovery-RP-
Amide-C16 phase, Eqn. 8 and, after removal of the insignificant variable, Eqn. 8a, and
for the ODP-50-4B phase, Eqn. 9 and, after removal of the insignificant variables,
Eqn. 9a.Eqn. 8a shows that the main factors governing retention on theDiscovery-RP-
Amide-C16 phase are the solute×s molecular volume (Vw) and H-bond acceptor basicity
(), while the importance of dipolarity/polarizability (*) is smaller and the H-bond
donor acidity () is not significant. Eqn. 9a reflects the different balance of structural
parameters controlling log kw on the ODP-50-4B phase, for which Vw and  are
important parameters, whereas * and  are not significant.
log kw 2.65 ¥ 102(0.46 ¥ 102) ¥Vw 0.49(0.45) ¥*
 2.58(0.58) ¥ 0.30(0.64) ¥ 0.28(0.64) (8)
n 41, q2 0.86, r2 0.88, s 0.50, F 66
log kw 2.72 ¥ 102(0.44 ¥ 102) ¥Vw 0.48(0.44) ¥*
 2.62(0.57) ¥  0.24(0.63) (8a)
n 41, q2 0.87, r2 0.88, s 0.50, F 87
log kw 2.18 ¥ 102(0.38 ¥ 102) ¥Vw 0.12(0.36) ¥*
 2.18(0.47) ¥  0.16(0.55) ¥ 0.69(0.52) (9)
n 41, q2 0.84, r2 0.86, s 0.52, F 56
log kw 2.12 ¥ 102(0.34 ¥ 102) ¥Vw 2.27(0.32) ¥ 0.63(0.46) (9a)
n 41, q2 0.85, r2 0.86, s 0.40, F 114
To allow a better comparison, the log Poct values were also analyzed by LSERs,
yielding Eqn. 10. After removal of the insignificant variable, Eqn. 10a is obtained.
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log Poct 2.40 ¥ 102(0.42 ¥ 102) ¥Vw 0.42(0.40) ¥*
 2.41(0.52) ¥ 0.01(0.64) ¥ 0.41(0.57) (10)
n 41, q2 0.87, r2 0.88, s 0.45, F 67
log Poct 2.41 ¥ 102(0.38 ¥ 102) ¥Vw 0.42(0.40) ¥*
 2.41(0.51) ¥ 0.41(0.56) (10a)
n 41, q2 0.87, r2 0.88, s 0.45, F 92
One can see from Eqns. 10 and 10a that Vw and  are the two main structural
properties governing the partitioning mechanism in octan-1-ol/H2O, whereas * is of
lesser significance and  is devoid of any significance. The ratios of the normalized
regression coefficients in Eqns. 8a and 10a are nearly identical (details not shown),
meaning that the same balance of intermolecular forces is encoded by log Poct and
log kw measured on the Discovery-RP-Amide-C16 phase. This finding confirms the
highly significant correlation between these two parameters as shown in Eqn. 6.
A comparison between Eqns. 9a and 10a indicates that the balance of forces
encoded by log kw measured on theODP-50-4B phase is different from that encoded by
log Poct , explaining the lower correlation between these two parameters (Eqn. 7).
When the structural descriptors were included in Eqn. 7, the correlation quality
becomes higher as shown by Eqn. 11 and, after removal of the insignificant term,
Eqn. 11a. The correlation coefficient in Eqn. 11a is better than that in Eqn. 7, but it
remains lower than that between log Poct and log kw on the Discovery-RP-Amide-C16
phase (Eqn. 6).
log Poct 0.80(0.26) log kw 0.65 ¥ 102(0.64 ¥ 102) ¥Vw
 0.32(0.28) ¥* 0.66(0.67) ¥  0.14(0.43) ¥ 0.14(0.44) (11)
n 41, q2 0.94, r2 0.94, s 0.32, F 118
log Poct 0.80(0.26) log kw 0.70 ¥ 102(0.62 ¥ 102) ¥Vw
 0.32(0.28) ¥* 0.70(0.66) ¥  0.12(0.42) (11a)
n 41, q2 0.94, r2 0.94, s 0.31, F 150
Conclusions. ± For the two stationary phases investigated, linear relationships were
found between isocratic log k and the volume fraction of MeOH in the eluent. The
significant correlation between the derived parameters log kw and slope S (Eqn. 2)
implies that these two parameters encode the same information under the experimental
conditions of the present study.
By using a wide range of solutes (including drugs) and eluents enriched in octan-1-
ol, the silica-based Discovery-RP-Amide-C16 phase yielded a lipophilicity index log kw
which was better correlated with log Poct than the log kw index obtained with the
 	
  ± Vol. 87 (2004)2874
polymer-based ODP-50-4B phase. A LSER analysis showed that retention on the
Discovery-RP-Amide-C16 phase and partitioning in octan-1-ol/H2O are controlled by
the same balance of structural properties, namely Van der Waals volume (Vw), H-bond
acceptor basicity (), and dipolarity/polarizability (*). In contrast, the retention
mechanism on the ODP-50-4B phase is governed by a different balance of structural
properties.
This work was supported by the 21st Century COE Program,Human Nutritional Science on Stress Control,
Tokushima, Japan.
Experimental Part
Solutes and Reagents. All compounds were obtained from commercial sources (Wako, Osaka, Japan; TCI,
Tokyo, Japan; Sigma-Aldrich, Tokyo, Japan, and Steinheim, Germany; ICN, Aurora, USA; Merck, Schuchardt,
Germany) and in the highest available purity. Dist. H2O, HPLC-grade MeOH, and octan-1-ol (Sigma-Aldrich,
Steinheim, Germany) were used throughout.
Selection of the solutes. A set of 41 compounds with exper. log Poct values ranging from  0.69 to 4.80 were
selected. This set consists of model compounds and drugs having a relatively rigid structure and well-defined
parameters (Vw, *, , and ) [36]. The investigated compounds and their physicochemical parameters are
shown in Table 1. The broad range of parameter spaces (Vw, *, , and ) is demonstrated in Fig. 2.
Measurement of Capacity Factors. The capacity factors were measured with a liquid chromatograph
equipped with a 880-PU-HPLC pump, a 875-UV/Vs detector (both from Jasco, Tokyo, Japan), a 655A-40
autosampler, and a D-2000 chromato-integrator (both from Hitachi, Tokyo, Japan). The Supelcosil Discovery-
RP-Amide-C16 column (5 cm 4.6 mm i.d., 5 m) was from Supelco (Bellefonte, PA, USA) and the Asahipak
ODP-50-4B column (5 cm 4.6 mm i.d., 5 m) from Asahi Chemicals (Kawasaki, Japan). The mobile phase
consisted of 0.02 phosphate buffer and MeOH in varying proportions (80 10% v/v). The phosphate buffer
was adjusted to pH 7 for all nonionizable compounds and to a pH value (pH 3, 4, or 7) where the neutral form
was in large excess for the ionizable compounds. To increase the similarity with octan-1-ol/buffer partitioning
[15] [22], a 0.25% (v/v) amount of octan-1-ol was added to MeOH, and octan-1-ol-sat. H2O was used to prepare
the buffer. The phosphate buffer was filtered under vacuum through a 0.45-m HA-Millipore filter (Millipore,
Milford, MA, USA) before being mixed with MeOH. The retention times tR were measured at r.t. by the UV/Vs
detector at wavelength max of the analytes. The solns. to be injected (104  to 103 ) were prepared by
dissolving the solutes in the mobile phase; the injection volume was 10 l. Uracil was used as the unretained
compound. On theDiscovery-RP-Amide-C16 phase, the measurements were carried out at a flow rate of 1.0 ml/
min for compounds with a log Poct value higher than 1, and 0.5 ml/min for compounds with log Poct below 1. Since
the highest pressure limit of theODP-50-4B column is much lower (ca. 730 psi) than that of silica-based columns
(4000 psi), a low flow rate (0.5 ml/min) was used for theODP-50-4B phase to prolong its life. In all cases, three
different MeOH concentrations were used for extrapolation to log kw. MeOH concentrations were adapted to
the log Poct values of the solutes as described in Table 2. The capacity factor log k was calculated by Eqn. 1. All
log k values were the average of three measurements. The log k values were then extrapolated to 100% H2O by
using Eqn. 2.
Statistical Analysis. All regression analyses were performed via the JMP statistical software package
(version 5.1.1, Japanese Edition, SAS Institute Inc).
Table 2. Concentrations of Organic Modifier (MeOH) Used with the Two Stationary Phases
log Poct of solutes % MeOH
Discovery-RP-Amide-C16 ODP-50-4B
 3 60, 65, 70 70, 75, 80
1 ± 3 40, 45, 50 60, 65, 70
 1 10, 20, 25 20, 30, 40
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Abstract
Lipophilicity was evaluated using a novel RP-HPLC stationary phase (Discovery-RP-Amide-C16) with and without 1-octanol added to the
mobile phase. A set of 46 drugs and flavonoids characterized by a broad structural diversity and a wide logPoct range (−0.69 to 5.70) was
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delected for this study. This set consists of neutral solutes and solutes with acidic or ampholytic functionalities which were maintained neutral
t pH 2.5 or 4. In our conditions, the addition of 1-octanol in the mobile phase proved a key factor to derive a lipophilicity index log kw highly
orrelated with logPoct for all investigated solutes. 1-Octanol improved the correlation between logPoct and log kw mainly by influencing
he retention behavior of the solutes with logPoct values below +3. This study brings additional evidence that under proper experimental
onditions of stationary and mobile phases, RP-HPLC is a very useful method to obtain logPoct values.
2005 Elsevier B.V. All rights reserved.
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. Introduction
Since many years, lipophilicity is recognized as a mean-
ngful parameter in structure–activity and structure–ADME
elationships. It is also the single most informative
nd successful physicochemical property in medicinal
hemistry. Not only has lipophilicity found innumerable
pplications in quantitative structure–activity relationships
QSARs) and quantitative structure-pharmacokinetic rela-
ionships (QSPkRs), but its study has revealed a wealth
f information on intermolecular forces, intramolecular
nteractions, and molecular structure in the broadest sense
1–4].
The most widely used measure of lipophilicity is the parti-
ion coefficient in the 1-octanol/water system (noted logPoct).
he reference procedure to measure logPoct is the shake-
∗ Corresponding author. Tel.: +81 88 633 9508; fax: +81 88 633 9508.
E-mail address: xliliu@yahoo.com (X. Liu).
flask method, which however is time-consuming and limited
in range (ca. −3 < logP< 4). Beyond these limits, logPoct
values measured by the shake-flask method become unreli-
able.
The reversed-phase HPLC (RP-HPLC) method is a
promising alternative to the shake-flask method, having
such advantages as a higher throughput, an insensitiv-
ity to impurities or degradation products, and a broader
lipophilicity range. In RP-HPLC, lipophilicity indices are
derived from the capacity factor log k, which is calculated by
Eq. (1):
k = tr − t0
t0
(1)
where tr and t0 are the retention times of the solute and of
an unretained compound, respectively. Some workers have
used isocratic log k values measured in an appropriate mobile
phase as a lipophilicity parameter [5–7]. However, many
more investigators have used capacity factors extrapolated
021-9673/$ – see front matter © 2005 Elsevier B.V. All rights reserved.
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to 100% water (log kw) to eliminate organic solvent effects
[8–13], and they have indeed demonstrated the usefulness of
the log kw parameter when investigating series of solutes cov-
ering a broad lipophilicity range. Generally, the extrapolation
to 100% water is based on a quadratic relationship between
the isocratic capacity factor log k and the volume fraction of
organic solvent in the mobile phase, ϕ [14]. When methanol
is used as the organic modifier, a linear relationship (Eq. (2))
is often obtained for neutral solutes [15,16]:
log k = −Sϕ + log kw (2)
where S is the slope and log kw, the intercept of the regression
curve.
Until recently, most lipophilicity studies were based on
RP-HPLC octadecyl silica (ODS) stationary phases. The
correlations between logPoct and log kw or log k values so
obtained are usually good for structurally related solutes
[15,17,18]. The decrease in correlation between capacity
factors and logPoct with increasing structural diversity of
solutes is believed to result from specific interactions of
the compounds with the residual silanol groups in such sta-
tionary phases [19]. Therefore it is a very big challenge
in this method to find the optimal stationary and mobile
phase conditions in order to obtain log kw values highly cor-
related with logP for a broad range of noncongeneric
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The authors also expanded the applicability of the method to
the determination of the 1-octanol/water distribution coef-
ficients (logDoct) at pH 7.4 for neutral and basic drugs
[13].
In order to further investigate the optimal conditions and
the applicable range for obtaining logPoct values from RP-
HPLC measurements, we selected here a set of 46 neutral
solutes and solutes with acidic and ampholytic functionali-
ties, which were maintained neutral at pH 2.5 or 4. We deter-
mined their log kw values on the Discovery-RP-Amide-C16
stationary phase using a methanol/phosphate buffer eluent
with and without 1-octanol. The compounds in this set are
all biologically active and cover a broad structural diversity
as well as a wide logPoct range (−0.69 to 5.70). They are
nonsteroidal anti-inflammatory drugs (NSAIDs), steroids,
4-phenyldihydropyridine (DHPs) calcium-channel blockers,
antibacterials and flavonoids, as shown in Fig. 1. The cor-
relation between log kw and logPoct values, and the relation
between log kw andS (see Eq. (2)), were explored. In addition,
the mechanism of the influence of 1-octanol in the mobile
phase on the log kw versus logPoct correlation was investi-
gated.
2. Experimental
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ompounds.
Measures have been taken to decrease the effects of free
ilanol groups. Great progress has been achieved with silica-
ased stationary phases exhibiting a high level of silanol
eactivation, of which LC-ABZ and Discovery-RP-Amide-
16 phases are good examples. In these stationary phases,
he alkyl chains contain an amido group which electrostati-
ally shields silanols from highly polar analytes. In addition,
t is hypothesized that the combination of amido groups
nd a hydration layer at the silica surface leads to a high
egree of orientation of the alkyl chains of the stationary
hase [20], which facilitates their hydrophobic interaction
ith the solutes, in contrast to what happens in conven-
ional ODS stationary phases where the alkyl chains are
ostly folded. The advantage of LC-ABZ over the con-
entional ODS stationary phases in logPoct measurement
as been verified and discussed [18,21–23]. A highly sig-
ificant correlation was found between logPoct and log kw
alues obtained with the Discovery-RP-Amide-C16 phase
or a wide range of compounds including model solutes and
rugs [24].
The influence of the mobile phase on the log kw versus
ogPoct correlation has also been investigated using dif-
erent organic modifiers [25,26] and/or adding low levels
f n-decylamine or 1-octanol [12,13,24,27,28]. Lombardo
t al. [12] investigated the influence of 1-octanol in the
obile phase on the logPoct measurement for a set of non-
ongeneric neutral drugs on LC-ABZ stationary phase. A
ighly significant correlation between log kw and logPoct was
btained in the presence of 1-octanol in the mobile phase..1. Solutes and reagents
All compounds were obtained from commercial sources
Wako, Osaka, Japan; TCI, Tokyo, Japan; Sigma–Aldrich,
okyo, Japan and Steinheim, Germany; ICN, Aurora, USA;
erck, Schuchardt, Germany; TRC, North York, Canada;
KT laboratories Inc. Tokyo, Japan) and in the highest avail-
ble purity. Distilled water, HPLC grade methanol, and 1-
ctanol (Sigma–Aldrich, Steinheim, Germany) were used
hroughout.
.2. Measurement of capacity factors
The capacity factors were measured with a liquid chro-
atograph equipped with a 880-PU-HPLC pump, a 875-
V–vis detector (both from Jasco, Tokyo, Japan), a 655A-40
utosampler and a D-2000 chromato-integrator (both from
itachi, Tokyo, Japan).
The column was a Supelcosil Discovery-RP-Amide-C16
5 cm× 4.6 mm I.D., 5m) from Supelco (Bellefonte, PA,
SA). The mobile phase consisted of 0.02 M phosphate
uffer and methanol in proportions varying from 70 to 10%
v/v). The phosphate buffer was adjusted to pH 3 for all neu-
ral drugs (steroids 16–23, DHPs calcium-channel blockers
4–29 in Table 2) and flavonoids (42–46 in Table 2), and
or the ionizable drugs to a pH value where the neutral form
as in large excess (pH 2.5 for NSAIDs 1–15 and pH 4 for
ntibacterials 30–41 in Table 2). Two sets of measurements
ere conducted for all compounds. In one set, a 0.25% (v/v)
mount of 1-octanol was added to methanol [27,28], and 1-
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octanol saturated water was used to prepare the buffer. In the
other set, the mobile phase condition was the same as that
used in the first set except for the absence of 1-octanol in
the eluents. The phosphate buffer was filtered under vacuum
through a 0.45m HA Millipore filter (Millipore, Milford,
MA, USA) before being mixed with methanol. The retention
times were measured at ambient temperature by the UV–vis
detector at the λmax of the analytes.
The solutions to be injected (10−4 M to 10−3 M) were
prepared by dissolving the solutes in the mobile phase; the
injection volume was 10L. Uracil was used as the unre-
tained compound. The measurements were carried out at aFig. 1. Structures of the drugs and flavonoids under study.
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Fig. 1. (Continued ).
flow rate 1.0 mL/min for compounds with a logPoct value
higher than +1, and 0.5 mL/min for compounds with logPoct
below +1. In all cases, three different methanol concentra-
tions were used for extrapolation to log kw. Methanol con-
centrations were adapted to the logPoct values of the solutes
as described in Table 1.
The capacity factor log k was calculated by Eq. (1). All
log k values were the average of three measurements. The
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Table 1
Concentrations of organic modifier (methanol) used in the two sets of
experiments
logPoct of the solutes %MeOH
>3 60, 65, 70
1–3 40, 45, 50
<1 10, 20, 25
log k values were then extrapolated to 100% water using Eq.
(2).
2.3. Statistical analysis
All regression analyses were performed via the JMP sta-
tistical software package (Version 5.1.1, Japanese Edition,
SAS Institute Inc.).
3. Results and discussion
3.1. Relationship between log k and ϕ
A linear relationship between log k and ϕ (the volume
fraction of organic solvent in the eluent) was found for
all compounds under both eluent conditions. In all cases,
the squared correlation coefficient was higher than 0.99,
excepting sulfamoxole and sulfapyridine (r2 = 0.98) under the
mobile phase with the presence of 1-octanol. The log kw and
S (slope) values of the 46 solutes were calculated by Eq. (2)
and are presented in Table 2.
3.2. Correlation between log kw and S
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Fig. 2. Relationship between log kw and slope S (A) in the presence of 1-
octanol in the mobile phase and (B) in the absence of 1-octanol in the mobile
phase.
sulfapyridine (40) and epicatechin (43). The reason for sul-
fapyridine being an outlier is probably the lower quality of
the linear regression between log k versus ϕ. For the other
two outliers, no reason is apparent and further investigation
is needed. After omission of the three outliers, the correlation
between log kw and S becomes even better (r2 = 0.98).
Since the only difference between the two sets of experi-
mental conditions was the presence or absence of 1-octanol
in the mobile phase, the factor producing the much bet-
ter correlation between log kw and S is clearly the addi-
tion of 1-octanol. The significant correlation in Eq. (3A)
implies that S is controlled by the same intermolecular
forces as those in log kw, which are van der Waals vol-
ume, H-bond acceptor basicity and dipolarity/polarizability
as unraveled by a solvatochromic analysis in our previous
study [24]. On the contrary, the non-significant correlation
in the absence of 1-octanol (Eq. (3B) and Fig. 2B) means
that these two parameters encode different structural infor-
mation. A clear interpretation of S in this condition needs
further quantitative structure-property (here S) relationship
analysis.
In previous studies, good correlations between log kw
and S were obtained mostly for simple or closely relatedThe correlation between log kw and S was investigated
nder the two mobile phase conditions. Fig. 2 shows a large
ifference in statistical quality in the presence or absence
f 1-octanol. The correlation was highly significant in the
resence of 1-octanol (Eq. (3A) and Fig. 2A), while a poor
orrelation was established in the absence of 1-octanol (Eq.
3B) and Fig. 2B).
S = 0.86(±0.04) log kw + 1.70(±0.11)
n = 46; q2 = 0.97; r2 = 0.97; s = 0.24; F = 1549 (3A)
S = 0.36(±0.13) log kw + 3.54(±0.36)
n = 46; q2 = 0.41; r2 = 0.41; s = 0.50; F = 31 (3B)
In this and the following equations, 95% confidence limits
re in parentheses; n, the number of the compounds; q2, the
ross-validated correlation coefficient; r2, the squared corre-
ation coefficient; s, the standard deviation and F the Fisher’s
est.
In spite of the significant correlation between log kw and S
or the complete set of solutes in Eq. (3A), there are three
utliers as shown in Fig. 2A, namely sulfanilamide (38),
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Table 2
Investigated compounds and their physicochemical parameters
Number Solutes logPocta 1-Octanol in the mobile phase No 1-octanol in the mobile phase
log kwb Sc log kwd Se
NSAIDs
1 Antipyrine 0.17 −0.16 1.61 1.06 4.31
2 Aspirin 1.13 0.71 2.20 1.15 3.00
3 Diclofenac 4.40 3.53 4.70 3.45 4.60
4 Diflunisal 4.44 3.31 4.20 3.20 4.10
5 Fenbufen 3.39 2.66 4.00 2.54 3.80
6 Flufenamic acid 5.25 4.48 5.60 4.32 5.40
7 Flurbiprofen 3.81 3.54 4.90 3.39 4.70
8 Ibuprofen 3.87 3.62 4.90 3.34 4.50
9 Indoprofen 2.77 1.90 3.20 2.93 5.10
10 Ketoprofen 2.77 2.54 4.00 3.03 5.00
11 Mefenamic acid 5.12 4.24 5.30 3.96 4.90
12 Naproxen 3.06 2.72 4.10 2.58 3.90
13 Sulindac 3.42 2.73 4.30 2.89 4.50
14 Tolfenamic acid 5.70 4.62 5.60 4.33 5.20
15 Tolmetin 2.79 2.46 4.00 2.95 4.90
Steroids
16 Corticosterone 2.20 1.68 2.80 2.80 4.80
17 Dexamethasone 1.83 1.67 2.80 2.87 5.00
18 Estrone 3.13 2.89 4.10 2.84 4.00
19 Estradiol 4.01 3.26 4.40 3.02 4.00
20 Hydrocortisone 1.55 1.24 2.30 2.40 4.40
21 Hydrocortisone-21-acetate 2.19 1.89 3.00 3.00 5.00
22 Progesterone 3.57 3.17 4.40 3.13 4.30
23 Testosterone 3.29 2.57 3.80 2.66 3.90
DHPs caicium-channel blockers
24 Felodipine 4.80 3.70 4.90 3.86 5.10
25 Lacidipine 5.56 4.47 5.80 4.78 6.20
26 Nifedipine 3.22 2.20 3.60 2.30 3.70
27 Nimodipine 4.18 3.14 4.50 3.37 4.80
28 Nisoldipine 4.53 3.39 4.70 3.62 5.00
29 Nitrendipine 4.15 2.93 4.20 3.02 4.30
Antibacterials
30 Sulfacetamide −0.16 −0.66 0.93 0.35 3.14
31 Sulfadimethoxine 1.40 0.87 2.70 1.97 4.50
32 Sulfadoxine 0.56 0.11 1.83 1.41 4.57
33 Sulfamethazine 0.25 −0.32 1.34 1.01 4.17
34 Sulfamethizole 0.55 0.07 1.85 1.18 4.36
35 Sulfamethoxazole 0.72 0.30 1.78 1.27 3.94
36 Sulfamethoxypyridazine 0.35 −0.18 1.40 1.14 4.36
37 Sulfamoxole −0.14 −0.32 1.81 1.07 4.63
38 Sulfanilamide −0.69 −1.30 0.00 −0.22 3.04
39 Sulfaphenazole 1.27 0.85 2.70 1.86 4.50
40 Sulfapyridine 0.02 −0.33 2.04 0.68 3.81
41 Sulfisomidine −0.37 −0.90 0.94 0.64 4.23
Flavonoids
42 Chrysin 3.52 3.27 4.30 3.16 4.10
43 Epicatechin 0.56 0.02 2.28 1.85 5.60
44 Fisetin 2.53 2.03 3.40 2.93 5.00
45 Flavone 3.56 2.52 3.70 2.46 3.60
46 Taxifolin 0.95 0.90 2.61 1.97 4.10
a The values of drugs 1–41 are taken from [12,29–32], those of flavonoids 42–46 are MlogP from the Bio-loom software [33].
b 0.01≤SD≤ 0.18.
c 0.01≤SD≤ 0.30.
d 0.01≤SD≤ 0.19.
e 0.01≤SD≤ 0.30.
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Fig. 3. Relationship between logPoct and log kw (A) in the presence of 1-
octanol in the mobile phase and (B) in the absence of 1-octanol in the mobile
phase.
compounds [10,14,15]. Here, significant correlations were
obtained for a structurally diverse set of chemically complex
drugs and flavonoids by using a 1-octanol enriched eluent. In
agreement with previous results [18], the slope of the corre-
lation between log kw and S in Eq. (3A) is close to unity.
3.3. Correlation between log Poct and log kw
The correlations between logPoct and log kw values
obtained with the two sets of eluents are also markedly dif-
ferent, with 1-octanol producing a significant improvement.
Eq. (4A) and Fig. 3A show that, in the presence of 1-octanol,
the correlation between logPoct and log kw was highly sig-
nificant for the whole set of solutes investigated. In contrast,
the correlation was good but of lower quality when 1-octanol
was absent (Eq. (4B) and Fig. 3B). This result is in agree-
ment with the work of Lombardo et al. [12], who compared
lipophilicity measurement in the presence or absence of 1-
octanol using a set of 27 structurally diverse neutral solutes
on a Supelcosil LC-ABZ column.
logPoct = 1.09(±0.05) log kw + 0.42(±0.13)
n = 46; q2 = 0.97; r2 = 0.98; s = 0.28; F = 1785 (4A)
logPoct = 1.50(±0.15) log kw − 1.19(±0.42)
n = 46; q2 = 0.89; r2 = 0.90; s = 0.58; F = 387 (4B)
In addition to the higher squared correlation coefficient
and smaller standard deviation of Eq. (4A) compared to Eq.
(4B), the slopes of these two equations are very different. As
stated by Minick et al. [27], the slope of an equation corre-
lating log kw and logPoct is an estimate of how closely the
free energies of the processes compare. A unit slope in such
a plot indicates that the two processes are homoenergetic.
In Eq. (4A), the slope is very close to unity, meaning that
the chromatographic retention process on the Discovery-RP-
Amide-C16 stationary phase with 1-octanol in the eluent is
very energetically similar to the partitioning process in 1-
octanol/water.
On the contrary, the large deviation from unity in the slope
in Eq. (4B) implies that RP-HPLC retention in the absence of
1-octanol and 1-octanol/water partitioning are governed by
dissimilar processes.
The above results show that, with a set of highly diverse
and functionally complex solutes (including neutral com-
pounds and ionizable compounds which were maintained
neutral at pH 2.5 or 4) and using the Discovery-RP-Amide-
C16 stationary phase, 1-octanol in the eluent is a key factor
to obtain a lipophilicity index log kw highly correlated with
logP . In other words, RP-HPLC with proper stationary and
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obile phases is a very promising alternative to the traditional
hake-flask method to derive logPoct values not only for neu-
ral drugs, as verified by Lombardo et al. [12], but also for
rugs with acidic and ampholytic functionalities, although,
eutral at the conditions studied.
As for the majority of basic drugs, logPoct values cannot
e determined with most silica-based stationary phases due
o the pH limitation of these stationary phases. Instead, their
istribution coefficient logDoct at pH 7.4 was successfully
etermined by this method [13].
The wide applicable range of the Discovery-RP-Amide-
16 stationary phase in lipophilicity measurement demon-
trated and confirmed the advantage of the amide embed-
ed stationary phases over the conventional ODS stationary
hases which could only be successful in logPoct measure-
ent of structurally related compounds. The reasons why
his kind of stationary phases is a better model for the 1-
ctanol/water partition system are possibly (1) the high level
f silanol deactivation on this stationary phase due to the elec-
rostatic coating and (2) the selective solvation of the silica
urface by water attracted into the bonded phase by the amide
roup as discussed by Dias et al. [22].
By comparing the log kw values obtained with the two sets
f experiments, Fig. 4 shows how the addition of 1-octanol to
he eluent differently affects the chromatographic retention
f solutes with logPoct values below and above a value of
. Indeed, all compounds with logPoct values greater than 3
open circles in Fig. 4) are close to the unity line, meaning
hat their log kw values are not influenced by the addition of
-octanol to the eluent. In contrast, the solutes with logPoct
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Fig. 4. Relationship between log kw values derived from the two set of exper-
iments.
values lower than 3 (closed circles in Fig. 4) deviate clearly
from the unity line, implying that the addition of 1-octanol
markedly decreases their log kw values. This is interpreted
to mean that the improved logPoct versus log kw correlation
resulting from the addition of 1-octanol is due mainly to a
modification of the retention behavior of the less lipophilic
solutes.
As shown in Table 1, the log kw values of the compounds
with logPoct values greater than 3 were extrapolated from
higher methanol concentrations (60, 65, 70%) in the eluent.
The negligible influence of 1-octanol on the retention behav-
ior of these solutes may be related to their specific properties
and/or to the higher methanol concentrations used.
4. Conclusion
Using the Discovery-RP-Amide-C16 stationary phase,
linear relationships were found between isocratic log k val-
ues and the volume fraction of MeOH in the eluent in the
presence and absence of 1-octanol. The correlation between
the derived log kw and S (Eq. (2)) is highly significant when a
1-octanol-enriched eluent was used, implying that under such
conditions the two parameters encode the same intermolec-
ular forces. In contrast, no significant correlation between
these two parameters was seen in the absence of 1-octanol.
f
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absence of 1-octanol, it can be concluded that the influence
of 1-octanol on the chromatographic retention is smaller for
the more lipophilic compounds (logPoct > 3) than for the less
lipophilic ones (logPoct < 3).
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Novel RPLC stationary phases for lipophilicity
measurement: Solvatochromic analysis of retention
mechanisms for neutral and basic compounds
An RPLC was developed to rapidly determine lipophilicity of neutral and basic com-
pounds using three base deactivated RPLC stationary phases particularly designed
for the analysis of basic compounds, namely, Supelcosil ABZ+Plus, Discovery RP
Amide C16, and Zorbax Extend C18. The work consisted of three sets of experiments.
In the first log kw values of neutral compounds were extrapolated using hydroorganic
mobile phases at different compositions. Good correlation between log kw and log Poct
indicated that the method was appropriate for these supports, without adding a silanol
masking agent. In the second set of experiments, isocratic log k values of neutral and
basic compounds were measured with three different mobile phases. The best esti-
mation of lipophilicity was obtained for neutral and basic compounds when the
secondary interactions were strongly reduced (i. e., when basic compounds were
under their neutral form). In the third set of experiments, isocratic retention factors of
basic compounds (in their neutral form) were measured with a high-pH mobile phase,
on a chemically stable support (Zorbax Extend C18). Under these chromatographic
conditions, correlation between the isocratic retention factors and log Poct (log D 10.5)
for basic compounds was similar to that for neutral compounds.
Key Words: Basic compounds; Neutral compounds; Quantitative structure–property relation-
ships; RPLC;
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1 Introduction
1.1 Lipophilicity determined by RP-HPLC
Lipophilicity is a well-known physicochemical descriptor
of xenobiotics and plays an essential role in the control of
a number of pharmacokinetic (regulation of transport to
site of action, toxicity, and metabolism) and pharmacody-
namic properties (e.g., interactions with targets or
enzyme induction). Lipophilicity is traditionally measured
using an n-octanol/water system because these partition
coefficients (log Poct) were in good agreement with model
lipophilic interactions for biological membranes.
Recent advances in automated synthesis and combina-
torial chemistry offer medicinal chemists access to a vast
number of potential drug candidates. The key role of lipo-
philicity in absorption, distribution, metabolism, elimina-
tion, and toxicity (ADMET) predictions has been widely
demonstrated by the early identification of potential phar-
macokinetic problems. The demand for fast methods to
measure lipophilicity parameters has grown rapidly in the
last few years.
For many years, the conventional and time-consuming
procedure to measure log Poct was a shake-flask method,
which was limited to a narrow range of log Poct values,
namely, –3 a log Poct a 3 [1, 2]. In order to overcome the
disadvantages of this technique, various chromatographic
methods such as TLC [3], centrifugal partition chromato-
graphy (CPC) [4], and RP-HPLC have been extensively
studied. In particular, the benefits of chromatographic
methods to give access to suitable lipophilicity parameters
were underlined in recent reviews [5, 6].
To derive the most suitable experimental conditions,
retention on several RP-HPLC stationary phases was
determined for a set of varying model compounds.
Indeed, in RP-HPLC methods, the lipophilicity index is
derived from the retention factor log k, where k is given by
Eq. (1)
k ¼ ðtr  t0Þ=t0 ð1Þ
where t r and t 0 are the retention time of the solute and of
an unretained compound, respectively. Both isocratic
log k values and extrapolated log kw (retention factor at
100% of water) values are used. The former being
obtained at a specific mobile phase concentration, and
the latter by extrapolation at 100% water plotting isocratic
log k values as a function of the mobile phase composi-
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tion. Thus, the relationships between different retention
factors and partition coefficients in n-octanol/water sys-
tem were carefully examined. The balance of intermolecu-
lar interactions revealed by these lipophilicity indices was
then analyzed in depth by quantitative structure–property
relationships (QSPR).
The intermolecular forces responsible for the retention on
RP-HPLC phases can be determined by solvatochromic
analysis, a method based on linear solvation-energy rela-
tionships (LSERs). This method was first used to evaluate
and identify the intermolecular interaction forces underly-
ing the partitioning mechanisms of solutes in various
organic/aqueous biphasic systems [7–10]. This approach
was introduced into chromatography and extensively
developed by various authors [11–13] in order to charac-
terize RPLC stationary phases [12, 14–18]. LSERs can
be expressed by the multilinear Eq. (2)
Sp ¼ m NVw þ p Np þ a Naþ b Nbþ c ð2Þ
In this equation, Sp is a given molecular property of a neu-
tral organic solute. In this study, this parameter corre-
sponds to log Poct or retention factors log kw determined
on RPLC stationary phases. The structural parameters
represent a steric term (van der Waals volume Vw) and
polar terms known as solvatochromic parameters (dipo-
larity/polarizability p*, hydrogen-bond donor acidity a, and
hydrogen-bond acceptor basicity b). The steric term
accounts for solvophobic/hydrophobic and dispersive
forces, and the polar terms account for polar interactions
between solutes and solvents. The regression coefficients
m, p, a, and b reflect the absolute contribution of each
solute parameter toSp, and c is a constant.
1.2 Stationary phases used in lipophilicity
measurements
Octadecyl silica (ODS) columns were commonly used for
lipophilicity measurements [19–21]. When used with an
aqueous methanol mobile phase, important correlations
can be obtained between measured retention factors
(log k and log kw) and literature log Poct values. However, it
is known that conventional ODS stationary phases con-
tain free acidic silanol groups which can interact with
strong hydrogen-bonding compounds and can cause
peak tailing and incorrect estimation of lipophilicity [22].
Compared to n-octanol/water system, where only the par-
titioning mechanism exists, silanophilic interactions of the
solute-stationary phase result in a dual mechanism of
retention (i.e., ion exchange and partition) [23, 24].
Silanophilic interactions can be strongly reduced, or even
suppressed, by the addition of a masking agent (e.g., n-
decylamine, triethylamine) to the mobile phase. Lom-
bardo et al. [11] used n-decylamine for lipophilicity deter-
mination of neutral and basic compounds and found that
its presence was necessary for the reliability of the
method. A different approach explored to reduce silanol
activity was the use of new stationary phases possessing
functional groups introduced to mask free silanol groups.
These supports were specially developed for the analysis
of basic compounds and are named base deactivated sta-
tionary phases [25]. Another important factor to obtain
precise results was the column-to-column reproducibility
[11]. In this reported study, different base deactivated sup-
ports known for possessing good batch-to-batch reprodu-
cibility were selected and used to determine the lipophili-
city of neutral and basic compounds.
1.3 Retention factors as lipophilicity indices
In general, for lipophilicity determination, the retention fac-
tor extrapolated at 100% of water (kw) was preferred to
isocratic retention factors k (measured at a given organic
solvent concentration) [26]. Hence, the correlation
between log kw values of neutral compounds (measured
on base deactivated supports) and their log Poct values
were examined using a set of model compounds.
Encouraging results were obtained with this series of
compounds; thus, the performance of these stationary
phases for the lipophilicity determination of basic com-
pounds was examined further.
With basic solutes, many factors must be taken into
account when working with buffered mobile phases in the
presence of organic solvents. Organic solvents can affect
the pK a of several components: the buffer compounds,
leading to pH changes in the mobile phase, the acidic sila-
nol groups on the surface of stationary phase (leading to
subtle changes in the intensity of ion-exchange mechan-
isms), and the solute itself. In general, the pK a of acids
increases as the organic solvent concentration increases,
whereas the pK a of bases decreases. Substantial struc-
ture-dependent differences in pK a shifts for bases from
their aqueous values at a given solvent composition were
reported in the literature [27], implying a variable correc-
tion of pK a values of basic compounds for each organic
solvent concentration. Thus, even if the effect of organic
solvent on pK a of model compounds can be roughly esti-
mated, this prediction is much more complicated for new
compounds with a high structural diversity.
In order to minimize effects from the organic modifier, an
alternative approach for basic compounds would be to
directly measure the retention factor of basic compounds
in a 100% aqueous mobile phase. The effect of pH can
then be better controlled but, under these chromato-
graphic conditions, lipophilic compounds would be highly
retained on RP support. Due to these problems, for basic
compounds a fixed organic solvent concentration was
used in order to derive isocratic retention factors as lipo-
philicity indices, designed to correlate with the distribution
coefficients, log D pH, of ionized compounds. The hydroor-
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ganic mobile phases were selected because they are
commonly used to evaluate performances of RP-HPLC
stationary phases, by determining silanol activity at differ-
ent pH values with different organic modifiers [28, 29].
Finally, in order to improve estimation of log Poct for this
class of substances, isocratic retention factors were also
measured in a high-pH mobile phase; therefore, basic
compounds existed mostly in unionized form and second-
ary interactions with ionized silanol groups were strongly
reduced. Analyses were carried out on a chemically stable
support: Zorbax Extend C18, which, even if silica based, is
stable for a wide range of pH values (2.0–11.5).
2 Materials andmethod
2.1 Solutes
All model neutral compounds were obtained from Merck
(Darmstadt, Germany), Fluka (Buchs, Switzerland), Jans-
sen (Beerse, Belgium), and Aldrich (Steinheim, Germany)
at the highest available purity. ACN and methanol with
superpure quality for HPLC were purchased from Romil
Chemicals (Cambridge, UK) and SDS (Peypin, France).
Water (R = 18 MXM6cm) was obtained with the Milli-Q
Water Purification System from Millipore (Milford, MA,
USA). Aqueous buffers were prepared with dipotassium
hydrogen phosphate anhydrous and potassium dihydro-
gen phosphate from Fluka by measurement of the pH with
a Metrohm pH-meter (Herisau, Switzerland). Ammonia
buffer was prepared with ammonia chloride supplied from
Fluka. The pH measured corresponded to the pH of the
aqueous buffer solution (without methanol or ACN).
The basic compounds used were selected to possess a
range of physicochemical properties, on the basis of the
literature [30] and previous works [31]. Basic compounds
were of analytical reagent grade and obtained from sev-
eral sources. Procainamide hydrochloride, nicotine, pyri-
dine, and benzylamine were provided by Fluka. Nortripty-
line hydrochloride was obtained from Sigma (Buchs, Swit-
zerland). Diphenhydramine hydrochloride, morphine
hydrochloride, and codeine were supplied by Siegfried
(Zofingen Switzerland). Amphetamine was obtained from
Socolabo Alltech (Wallisellen, Switzerland). Methadone
hydrochloride and quinine hydrochloride were from Hn-
seler AG (Herisau). Fentanyl citrate was from Macfarlan
Smith (Edinburgh, Scotland). Mepivacaine hydrochloride
and chloroprocaine hydrochloride were provided by Orga-
mol (Evionnaz, Switzerland).
2.2 Multivariate statistical analysis
The LSERmodels were generated by multivariate regres-
sion using both the TSAR program (Oxford Molecular,
Oxford, GB) running on windows PC and the QSAR mod-
ule in the Sybyl software (Tripos Associates, St. Louis,
MO, USA), running on Silicon Graphics Indy R4400
175 MHz, O2 R5000 180 MHz, or Origin 2000 R10000
195 MHz workstations. Van der Waals volumes (Vw) were
calculated with the standard software MOLSV (QCPE No.
509) and the atomic radii of Gavezzotti. The relative con-
tributions of each variable to the LSER models were
obtained by Mager's standardization [32].
2.3 Selection of an optimal set of neutral
compounds using cluster analysis
An optimal set of 80 compounds was selected by cluster
analysis from 253 organic compounds with known solva-
tochromic parameters and known n-octanol/water parti-
tion coefficients determined by Pagliara et al. [33]. Com-
pounds of the optimal set, together with their parameters
(Vw, p*, b, a) and partition coefficients (log Poct), are given
in [34]. It should be noted that this set of neutral com-
pounds contains some ionizable compounds. These com-
pounds are measured at a pH where their neutral form is
dominant.
Different reduced sets of model compounds were investi-
gated because of problems associated with compound
availability and poor UV detection. Selections were per-
formed to ensure that each set of compounds had a struc-
tural diversity (in terms of Vw, a, b, p*, and log Poct) com-
parable to the diversity of the optimal set of 80 solutes [9,
10, 33]. To extrapolate retentions factors, a reduced set of
45 UV active compounds was used while the number of
test compounds used in each set of experiments was vari-
able, when different experimental conditions (mobile
phase/stationary phases, pH of mobile phases) were
used to measure isocratic retention factors.
2.4 Measurement of retention factors
The selected columns were a Supelcosil ABZ+Plus
(15 cm64.6 mm ID, 5 lm, 100 ), a DiscoveryTM RP
Amide C16 (15 cm64.6 mm ID, 5 lm, 100 ), both from
Supelco (Bellefonte, PA, USA), and a Zorbax Extend C18
(15 cm64.6 mm ID, 5 lm, 100 ) from Agilent Technolo-
gies (Palo Alto, CA, USA).
The retention factors of the different sets of neutral and
basic compounds were measured on Supelcosil ABZ+-
Plus and Discovery RP Amide C16 stationary phases with
a liquid chromatograph (Kontron MT1) equipped with an
HPLC pump model 420, an autosampler 460, a column
oven 480, an oven controller 480, and a UV-VIS detector
model 430 (Kontron, Zurich, Switzerland). For UV inactive
compounds, a refractive index (RI) detector (Erma refract-
ometer, Tokyo, Japan) was employed.
Retention factors for the 45 UV active compounds were
measured on the Zorbax Extend C18 with a Merck-Hitachi
LaChrom system (Darmstadt, Germany) composed of an
L-7100 pump, an L-7200 autosampler, and an L-7400 UV-
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VIS detector. Data acquisition and evaluation were per-
formed by the D-7000 HPLC SystemManager Software V
4.0.
The retention factors of basic compounds at pH 7.0 on
Zorbax Extend C18 stationary phase were measured with
aMerck-Hitachi LiChrograph, consisting of an L-6200 pro-
grammable pump, an AS-2000 automatic injector with
100 lL loop, and an L-4250 UV-VIS programmable detec-
tor operating at 215 nm. Data acquisition and evaluation
were performed by the D-7000 HPLC System Manager
Software.
For the measurements of retention factors (of neutral and
basic compounds) at high-pH values, a Dionex GP50
(Sunnyvale, CA, USA) system was used. Pump heads
were made of PEEK (chemically resistant from pH 1 to
14). The HPLC system was equipped with an HP 1050
UV-VIS programmable detector operating at 215 nm.
To determine the extrapolated retention factors, several
log k values were measured for each neutral compound
using methanol/pH 7.0 phosphate buffer and ACN/pH 7.0
phosphate (results not reported) buffer mixtures contain-
ing 10:65 v/v of organic modifier. Higher concentrations
of organic modifier were not possible due to phosphate
buffer precipitation under these conditions (0.0225 M in all
mixtures).
To measure isocratic retention factors, three mobile
phases were used: ACN/0.0375 M phosphate buffer
pH 7.0 (40 :60, v/v); methanol/0.0643 M phosphate buffer
pH 7.0 (65 :35, v/v); and ACN/0.0265 M phosphate buffer
pH 3.0 (15 :85, v/v). The phosphate buffer was filtered
under vacuum through a 0.45 lm HA Millipore filter (Milli-
pore) before being mixed with an organic modifier.
For the analyses carried out at high-pH, the mobile phase
was ACN/0.315 M ammonia buffer adjusted to pH 10.5
(40 :60, v/v).
For all mobile phases, the given pH is the pH of the buffer
before the addition of organic modifier. The pH of the
mobile phase was not corrected, since this did not
improve extrapolation [34].
3 Results and discussion
3.1 Extrapolated log kwvalues onABZ+Plus and
Discovery RPAmide C16 stationary phases
In the first set of experiments, isocratic retention factors of
neutral compounds were measured on two embedded
polar group stationary phases, namely, Supelcosil ABZ+-
Plus and Discovery RP Amide C16. Retention factors
obtained at various concentrations of methanol were
extrapolated to 0% of organic solvent using a conven-
tional least square procedure and reported as log kw in
Tables 1, 2. For the 45 investigated compounds, linear
relationships between log k and volume fraction of metha-
nol were observed over the range of eluent composition
studied (10–65%, v/v) on the two stationary phases. Cor-
relations between log kw and log Poct values obtained with
both stationary phases are described by Eqs. (3), (4) and
reported in Fig. 1.
Supelcosil ABZ+Plus:
log Poct = 1.08(l0.05) N log w + 0.02(l0.11)
n = 45, r 2 = 0.98, s = 0.17, F = 2170 (3)
Discovery RP Amide C16:
log Poct = 1.13(l0.06) N log w + 0.28(l0.12)
n = 45, r 2 = 0.97, s = 0.21, F = 1506 (4)
In these and subsequent equations 95% confidence limits
are in parentheses, n is the number of compounds, r 2 is
the coefficient of determination (squared correlation coef-
ficient), s is the SD, and F is the Fisher value.
On both base deactivated supports, the log kw values
gave good correlation to log Poct as the slopes were very
close to unity and had a small value for the intercept.
These results underline that the two embedded polar
group stationary phases examined offer lipophilicity
indices (extrapolated retention factors, log kw), which
allow fast estimation of the partition coefficients in an n-
octanol/water system in the range of –0.8 a log Pocta 4.8.
Moreover, the good correlations obtained suggest that
log kw (measured on the two stationary phases) and log
Poct are governed by similar structural parameters.
In order to unravel the structural properties governing
retention mechanisms and to compare them with parti-
tioning in the n-octanol/water system, linear solvation
free-energy relationships (LSERs) were applied to the two
sets of log kwvalues and log Poct values. These results are
reported in Table 3.
The relative contributions of each variable to log kw values
obtained by Mager's standardization [32] can be seen in
Table 4. Results show that the principal factors governing
log kw values are the van der Waals volume (Vw) and
hydrogen-bond acceptor basicity (b), while dipolarity/
polarizability (p*) and hydrogen-bond donor acidity (a) are
of less importance.
Partition coefficientsmeasured in the n-octanol/water sys-
tem (log Poct) were analyzed by LSERs using the same set
of neutral compounds (see Tables 3, 4). The good agree-
ment of the calculated parameters confirmed that parti-
tioning in the n-octanol/water system and the extrapolated
retention factor (in the situation of 0% of organic modifier)
for the two stationary phases are governed by similar
structural parameters.
For basic compounds, extrapolation of the retention fac-
tors to 100%water was not performed due to the influence
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Table 1. Retention factors measured on Supelcosil ABZ+Plus stationary phase
Numbera) Solute log PNoct
b) log kw;MeOHc) log k 1d) log k 2e) log k 3f)
2 CH2Cl2 1.15 g 0.14 –0.27 0.48
3 CHCl3 1.94 g 0.44 –0.03 1.02
4 CCl4 2.63 g 0.79 0.3 h
5 CH2ClCH2Cl 1.48 g 0.23 –0.2 0.7
6 CHCl2CHCl2 2.39 g 0.63 0.12 h
7 CH3(CH2)3Cl 2.64 g 0.71 0.25 h
8 (C2H5)2O 0.89 g –0.14 –0.5 0.13
9 (n-C3H7)2O 2.03 g 0.50 0.04 1.16
10 CH3COOCH3 0.18 –0.09 –0.44 –0.89 –0.27
11 CH3COOC2H 0.73 0.46 –0.22 –0.68 0.13
12 n-CH3COOC4H9 1.82 1.67 0.31 –0.18 1.04
14 CH3CH2CN 0.10 g –0.39 –0.95 –0.29
15 CH3-CO-N(CH3)2 –0.77 –0.36 –0.94 i –0.72
16 CH3-CO-N(C2H5)2 0.34 0.58 –0.53 –0.92 –0.01
18 n-C3H7OH 0.28 g –0.58 –0.80 –0.36
19 (CH3)3COH 0.36 g –0.51 –0.72 –0.23
20 n-C5H11OH 1.40 g –0.01 –0.32 0.60
21 CH3CH2C(CH3)2OH 0.93 g –0.25 –0.49 0.18
22 1-C6H13OH 2.03 g 0.27 –0.08 1.09
23 HCOOH –0.54 g i j –0.51
24 CH3COOH –0.24 g i i –0.67
25 n-C3H7COOH 0.79 0.58 i i 0.19
26 n-C4H9COOH 1.39 1.24 j j 0.65
27 n-C4H9NO2 1.47 g 0.26 –0.31 0.82
28 THF 0.46 g –0.37 –0.69 –0.16
29 C6H5CH3 2.69 2.23 0.72 0.29 1.56
30 C6H5-CO-CH3 1.58 1.46 0.16 –0.32 0.86
31 C6H5NO2 1.85 1.62 0.38 –0.08 1.09
32 C6H5OCH3 2.11 1.76 0.45 0.02 1.19
33 C6H5COOC2H5 2.64 2.45 0.61 0.10 1.62
34 C6H5-CO-C2H5 2.20 1.95 0.44 –0.09 1.29
35 C6H5COOCH2C6H5 3.97 3.63 1.09 0.54 k
36 2-Cl-C6H4NO2 2.24 2.18 0.56 0.06 1.48
37 C6H5CH2CN 1.56 1.48 0.22 –0.41 0.95
38 C6H5CH2-CO-CH3 1.44 1.41 0.17 –0.37 0.88
39 C6H5(CH2)2-O-CO-CH3 2.30 2.23 0.48 –0.04 1.48
40 Pyridine 0.65 0.54 –0.41 –0.78 i
41 Acridine 3.40 2.89 0.63 0.21 j
42 1-Naphthoic acid 3.10 2.82 j j 1.90
43 2-Naphthylamine 2.28 2.19 0.48 0.04 j
44 C6H5NH2 0.90 0.75 –0.05 –0.52 j
45 C6H5NHC2H5 2.16 1.75 0.51 –0.01 j
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Table 1. Continued
Numbera) Solute log PNoct
b) log kw;MeOHc) log k 1d) log k 2e) log k 3f)
46 2-Cl-C6H4NH2 1.91 1.64 0.38 –0.07 j
47 2-NH2-C6H4-C6H5 2.84 2.67 0.71 0.20 j
48 4,49-(NH2)2-Biphenyl 1.53 1.56 0.03 –0.57 j
49 4-NO2-C6H4-NH2 1.39 1.44 0.13 –0.31 0.85
50 C6H5OH 1.49 1.25 0.11 –0.29 0.71
51 3-Cl-C6H4OH 2.49 2.32 0.58 0.17 1.51
52 3-CH3-C6H4COOH 2.37 2.22 j j 1.37
53 C6H5CH2COOH 1.46 1.42 j i 0.83
54 3-Cl-C6H4CH2COOH 2.09 2.21 j j 1.46
55 C6H5(CH2)3COOH 2.42 2.39 j j 1.51
56 C6H5CH2OH 1.08 1.01 –0.11 –0.47 0.45
57 4-Cl-C6H4CH2OH 1.96 1.82 0.24 –0.11 1.10
58 4-NO2-C6H4-OH 1.92 1.81 j j 1.14
59 1,3-C6H4Cl2 3.48 3.15 1.06 0.62 k
60 Biphenyl 3.90 3.69 1.20 0.76 k
71 Naphthalene 3.35 3.06 0.97 0.54 k
72 1,3,5-C6H3(CH3)3 3.84 3.40 1.19 0.74 k
73 n-C9H19COOH 4.09 4.26 g g g
75 1,2,4,5-C6H2Cl4 4.51 4.16 1.55 1.12 k
77 C6H5(CH2)2C6H5 4.80 4.38 1.48 0.99 k
78 C6H(CH3)5 4.56 4.04 1.49 1.08 k
a) Same numbering as in [9, 34].
b) Values taken from [34].
c) Extrapolated retention factors using methanol as organic modifier.
d) log k measured using mobile phase 1 (MeCN/phosphate buffer pH 7.0 0.0375 M, 40 :60 v/v).
e) log k measured using mobile phase 2 (MeOH/phosphate buffer pH 7.0 0.0643 M, 65 :35 v/v).
f) log k measured using mobile phase 3 (MeCN/phosphate buffer pH 3.0 0.0265 M, 15 :85 v/v).
g) Not measured.
h) Not measured due to problems of solubility into the mobile phases.
i) Too hydrophilic compounds under the experimental conditions.
j) Compounds charged under the experimental conditions.
k) Too lipophilic compounds under the experimental conditions.
Figure 1. Relationships between extrapolated log kw and log Poct for (A) the Supelcosil ABZ+Plus and (B) the Discovery RP
Amide C16 stationary phases.
2356 Stella, Galland, Liu, Testa, Rudaz, Veuthey, Carrupt
of organic solvent on both the pK a of basic compounds
and buffer solution.
3.2 Isocratic log k values determined on
Supelcosil ABZ+Plus and Discovery RP Amide
C16stationary phases
For the reasons given above, in a second set of experi-
ments, the retention values of neutral and basic com-
pounds were also measured on Supelcosil ABZ+Plus and
Discovery RP Amide C16 using three isocratic mobile
phases, specially selected for the analysis of basic com-
pounds in RPLC [25].
Isocratic retention factors of neutral compounds, meas-
ured with the three mobile phases, were compared
between the two supports, with k 1 measured with ACN/
pH 7.0 phosphate buffer (40 :60, v/v), k2 measured with
methanol/pH 7.0 phosphate buffer (65 :35, v/v), and k 3
with ACN/pH 3.0 phosphate buffer (15:85, v/v).
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Table 2. Retention factors measured on Discovery RP
Amide C16 stationary phase
Numbera) log kw;MeOHb) log k 1c) log k 2d) log k 3e)
2 f 0.02 – 0.50 0.28
3 f 0.30 – 0.25 0.78
4 f 0.61 0.07 g
5 f 0.12 – 0.40 0.49
6 f 0.51 – 0.10 1.25
7 f 0.57 0.04 g
8 f – 0.25 – 0.65 – 0.05
9 f 0.36 – 0.15 0.96
10 – 0.34 – 0.53 – 1.02 – 0.38
11 0.23 – 0.28 – 0.78 0.00
12 1.42 0.22 – 0.31 0.88
14 f – 0.47 – 1.06 – 0.44
15 – 0.38 – 0.99 – 1.36 – 0.79
16 0.39 – 0.59 – 0.95 – 0.09
18 f – 0.69 – 0.94 – 0.56
19 f – 0.64 – 0.84 – 0.39
20 f – 0.17 – 0.48 0.40
21 f – 0.39 – 0.62 0.00
22 f 0.09 – 0.24 0.88
23 f h h – 0.64
24 f i h – 0.87
25 0.35 h i – 0.01
26 0.98 h i 0.44
27 f 0.18 – 0.47 0.65
28 f – 0.48 – 0.82 – 0.33
29 1.84 0.59 0.06 1.31
30 1.20 0.10 – 0.45 0.71
31 1.29 0.31 – 0.26 0.90
32 1.43 0.35 – 0.18 0.98
33 2.16 0.53 – 0.05 1.45
34 1.66 0.36 – 0.23 1.12
35 3.26 1.01 0.36 j
36 1.80 0.48 – 0.12 1.30
37 1.18 0.17 – 0.53 0.80
38 1.14 0.12 – 0.49 0.75
39 1.96 0.42 – 0.17 1.33
40 0.34 – 0.47 – 0.88 i
41 2.56 0.46 0.05 h
42 2.36 h i 1.53
43 1.71 0.33 – 0.25 h
44 0.46 – 0.15 – 0.72 h
45 1.38 0.41 – 0.20 h
46 1.25 0.27 – 0.30 h
47 2.31 0.62 0.00 h
48 1.22 – 0.03 – 0.74 h
49 1.09 0.07 – 0.48 0.68
50 0.88 – 0.01 – 0.50 0.47
51 1.87 0.42 – 0.08 1.23
52 1.85 h i 1.07
Table 2. Continued
Numbera) log kw;MeOHb) log k 1c) log k 2d) log k 3e)
53 1.12 i i 0.60
54 1.84 h h 1.12
55 2.07 h h 1.30
56 0.72 – 0.22 – 0.62 0.25
57 1.51 0.09 – 0.29 0.86
58 1.47 h h 0.95
59 2.75 0.89 0.36 j
60 3.25 1.04 0.48 j
71 2.60 0.81 0.26 j
72 3.00 1.02 0.48 j
73 3.94 f f f
75 3.73 1.34 0.82 j
77 3.94 1.34 0.72 j
78 3.66 1.31 0.80 j
a) Same numbering as in [9, 34].
b) Extrapolated retention factors using methanol as organic
modifier.
c) log k measured using mobile phase 1 (MeCN/phosphate
buffer pH 7.0 0.0375 M, 40 :60 v/v).
d) log k measured using mobile phase 2 (MeOH/phosphate
buffer pH 7.0 0.0643 M, 65 :35 v/v).
e) log k measured using mobile phase 3 (MeCN/phosphate
buffer pH 3.0 0.0265 M, 15 :85 v/v).
f) Not measured.
g) Not measured due to problems of solubility into the
mobile phases.
h) Too hydrophilic compounds under the experimental con-
ditions.
i) Compounds charged under the experimental conditions.
j) Too lipophilic compounds under the experimental condi-
tions.
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log k 1 (ABZ+Plus) = 1.04 (l0.02) N log k 1 (Discovery)
+ 0.10 (l0.01)
n = 52, r = 0.996, s = 0.04, F = 11590 (5)
log k 2 (ABZ+Plus) = 1.10 (l0.02) N log k 2 (Discovery)
+ 0.21 (l0.01)
n = 51, r = 0.995, s = 0.04, F = 9240 (6)
log k 3 (ABZ+Plus) = 1.05 (l0.02) N log k 3 (Discovery)
+ 0.10 (l0.02)
n = 43, r = 0.995, s = 0.05, F = 7810 (5)
This high correlation (slopes close to the unity and their
intercept very small for Eqs. (5)–(7)) suggests that the
retention mechanisms on the two stationary phases are
similar. Equations (5)–(7) also indicate that the effects of
the organic modifier and pH on the structure, ionization,
and solvation of the stationary phase are similar for the
two phases examined.
According to these results, isocratic retention factors
measured on both stationary phases were expected to
correlate in a similar way with the partition coefficients
(log Poct) of analyzed compounds. Consequently, relation-
ships between isocratic retention factors and log Poct were
then calculated for each mobile phase and chromato-
graphic support (Eqs. (8)–(15)).
With the set of neutral compounds tested in mobile phase
at pH 3.0 (Eqs. (8) and (9) for Supelcosil ABZ+Plus and
Discovery RP Amide, respectively), slopes differed from
unity (and intercepts differ from zero) more than for the
extrapolated isocratic factors (Eqs. (3), (4)) on both base
deactivated stationary phases.
log Poct = 1.29(l0.06) N log k 3 + 0.50(l0.06)
n = 43, r 2 = 0.97, s = 0.15, F = 1522 (8)
log Poct = 1.34(l0.08) N log k 3 + 0.72(l0.07)
n = 44, r 2 = 0.96, s = 0.18, F = 1020 (9)
These differences were associated with free-energy
changes due to the presence of 15% organic solvent
(ACN) in pH 3.0 mobile phase. This hypothesis was con-
firmed as the equations (Eqs. (10), (11)) obtained for neu-
tral compounds in a pH 3.0 mobile phase with a higher
amount of ACN (40% instead of 15%) have, as expected,
higher slopes and intercepts on both stationary phases
and different solvatochromic equations.
Supelcosil ABZ+Plus:
log Poct = 2.18(l0.10) N log k 40%MeCN + 1.90(l0.08)
n = 35, r 2 = 0.98, s = 0.17, F = 1730 (10)
Discovery RP Amide C16:
log Poct = 2.29(l0.16) N log k 40%MeCN + 1.65(l0.09)
n = 34, r 2 = 0.96, s = 0.22, F = 874 (11)
By increasing the organic modifier quantity, a decrease of
the volume contribution in LSER equations is obtained
(data not shown). This demonstrates that the presence of
an organic solvent facilitates the formation of cavities,
which are needed to dissolve solutes in aqueous mobile
phases.
Additional correlations between log Poct and isocratic
retention factors measured in pH 7.0 mobile phases were
also explored.
On Supelcosil ABZ+Plus stationary phase:
log Poct = 2.16(l0.11) N log k 1 + 1.23(l0.07)
n = 52, r 2 = 0.97, s = 0.22, F = 1531 (12)
log Poct = 2.27(l0.12) N log k 2 + 2.19(l0.06)
n = 51, r 2 = 0.97, s = 0.22, F = 1418 (13)
On the Discovery RP Amide C16stationary phase:
log Poct = 2.24(l0.13) N log k 1 + 2.68(l0.06)
n = 52, r 2 = 0.96, s = 0.25, F = 1189 (14)
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Table 3. Solvatochromic analyses of estimated retention factors and partition coefficients
Sp v (610 – 2) p a b c n q 2 r 2 s F
log k
ABZþplus
w;MeOH
3.05 (l0.26) – 0.33 (l 0.29) 0.32 (l0.20) – 3.65 (l0.30) – 0.26 (l 0.26) 45 0.98 0.99 0.14 713
log kDiscoveryw;MeOH
2.92 (l0.30) – 0.38 (l 0.34) 0.21 (l0.22) – 3.30 (l0.34) – 0.51 (l 0.27) 45 0.97 0.98 0.15 561
log kZorbaxw;MeOH
3.18 (l0.36) – 0.49 (l 0.36) – 0.31 (l0.28) – 3.60 (l0.49) 0.23 (l0.31) 40 0.95 0.96 0.20 216
logPoct 3.18 (l0.15) – 0.43 (l 0.15) 0.21 (l0.16) – 4.23 (l0.34) 0.10 (l0.27) 45 0.99 0.99 0.13 1031
Table 4. Relative contributions of each variable to the LSER
models obtained by Mager's standardization
n a) %VW % p* % a % b
log k
ABZþplus
w;MeOH
45 52.8 5.1 4.7 37.4
log kDiscoveryw;MeOH
45 54.2 6.2 3.4 36.2
log kZorbaxw;MeOH 40 52.8 7.3 4.7 35.2
logPoct 45 50.9 6.1 2.9 40.1
a) Number of compounds included in the LSER model.
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log Poct = 2.52(l0.11) N log k 2 + 2.68(l0.06)
n = 52, r 2 = 0.98, s = 0.18, F = 2278 (15)
It can be seen that an excellent correlation was found for
neutral compounds in all chromatographic conditions
(r 2 >0.96). However, the slopes and intercepts were sig-
nificantly different from 1 and 0, respectively, indicating
that the free-energy changes were not the same. If the
final goal was not the determination of log Poct, but a self-
consistent scale of lipophilicity, then isocratic log k would
be of major interest for the determination of the relative
lipophilicity, especially in a set of compounds character-
ized by high structural diversity.
In the same way, isocratic retention factors of basic com-
pounds were measured, plotted against their log D 7.0
values (Fig. 2), and compared with the relationships
between log Poct and log k 1 previously obtained for neutral
compounds under the same chromatographic conditions
(Eqs. (8), (10)). No clear correlation between log k 1 and
log Doct for basic compounds was found. This would sug-
gest that, at pH 7.0, basic compounds and free silanols
are, respectively, partially and completely charged indu-
cing strong ion-exchange interactions.
As described above, the effect of the organic modifier on
the ionization state of solutes, stationary phases, and on
the pH of mobile phases are difficult to distinguish. This
suggests that chromatographic supports and mobile
phases suitable for the analyses of basic compounds are
not suitably optimized for the estimation of lipophilicity.
Obtained results indicate that lipophilicity estimation with
an RP-HPLC method should be performed either with a
low amount of organic solvent (to remain closer to the par-
titioning in n-octanol/water system) or when basic com-
pounds are in their unionized form. However, with a low
amount of organic solvent in the mobile phase, basic com-
pounds can be strongly retained on the stationary phase.
For this reason, the use of a higher amount of organic sol-
vent was required in order to estimate the lipophilicity of
basic compounds in their unionized form.
3.3 Relationship between isocratic retention
factors of basic compounds and log Poct
On the basis of earlier findings, a reliable estimation of the
lipophilicity in the case of basic compounds calls for a
direct measurement of the retention of basic compounds
in their neutral form in order to estimate their log Poct. For
this purpose, retention factors have to be measured in a
high-pH mobile phase. Since classical silica-based sta-
tionary phases are only chemically stable only within a lim-
ited range of pH values (pH 2–8), this part of the study
was carried out on a more stable silica-based chromato-
graphic support: Zorbax Extend C18. This stationary phase
incorporates a bidentate silane, combined with a double-
endcapping process that protects silica from dissolution at
high pH, up to pH 11.5.
The correlation between the extrapolated log kw of neutral
compounds and their log Poct was investigated and com-
pared with the results previously obtained on Discovery
RP Amide C16 and Supelcosil ABZ+Plus.
Retention factors of only 40 compounds among the set of
45 UV active compounds were measured on the Zorbax
Extend C18 (Table 5) stationary phase because this phase
is slightly more lipophilic.
Equation (16) is quite similar to Eqs. (3), (4) obtained with
the two other stationary phases
log Poct = 1.01(l0.09) N log kw – 0.25(l0.21)
n = 40, r 2 = 0.93, s = 0.27, F = 524 (16)
As reported for Discovery RP Amide C16 and Supelcosil
ABZ+Plus, LSERs analyses (Tables 3, 4) were carried out
on results obtained on Zorbax Extend C18. Results
showed that the principal factor governing log kw values
on Zorbax Extend C18 was again the van der Waals
volume.
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Figure 2. Relationships between isocratic log k 1 and log D 7.0 on ABZ+Plus and Discovery RP Amide C16. (0) Set of 14 basic
solutes, (– ) set of neutral compounds.
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Table 5. Retention factors obtained on Zorbax Extend C18 stationary phase
Numbera) Solute log PNoct
b) log kw;MeOHc) log k 1d) log k 2e)
6 CHCl2CHCl2 2.39 f f 0.95
10 CH3COOCH3 0.18 0.42 f f
11 CH3COOC2H 0.73 1.04 f f
12 n-CH3COOC4H9 1.82 2.33 f f
15 CH3-CO-N(CH3)2 –0.77 0.07 –0.74 –0.78
16 CH3-CO-N(C2H5)2 0.34 1.18 –0.37 –0.41
25 n-C3H7COOH 0.79 1.01 f f
26 n-C4H9COOH 1.39 1.69 f f
27 n-C4H9NO2 1.47 f 0.48 f
29 C6H5CH3 2.69 2.91 f f
30 C6H5-CO-CH3 1.58 1.91 0.54 0.33
31 C6H5NO2 1.85 1.93 0.52 0.54
32 C6H5OCH3 2.11 2.22 0.91 f
33 C6H5COOC2H5 2.64 2.99 0.86 0.86
34 C6H5-CO-C2H5 2.20 2.43 0.65 0.65
35 C6H5COOCH2C6H5 3.97 4.45 f f
36 2-Cl-C6H4NO2 2.24 2.47 0.71 0.73
37 C6H5CH2CN 1.56 1.88 0.38 0.38
38 C6H5CH2-CO-CH3 1.44 1.93 0.37 0.37
39 C6H5(CH2)2-O-CO-CH3 2.30 2.82 0.73 0.75
40 Pyridine 0.65 0.99 –0.24 –0.37
41 Acridine 3.40 3.19 0.67 0.67
42 1-Naphthoic acid 3.10 2.69 f f
43 2-Naphthylamine 2.28 2.33 0.76 0.48
44 C6H5NH2 0.90 0.98 0.18 0.03
45 C6H5NHC2H5 2.16 2.19 0.71 0.70
46 2-Cl-C6H4NH2 1.91 1.88 0.47 0.45
47 2-NH2-C6H4-C6H5 2.84 3.11 0.87 0.89
48 4,49-(NH2)2-Biphenyl 1.53 1.70 –0.03 –0.02
49 4-NO2-C6H4-NH2 1.39 1.23 0.07 0.03
50 C6H5OH 1.49 1.27 0.37 g
51 3-Cl-C6H4OH 2.49 2.32 f f
52 3-CH3-C6H4COOH 2.37 2.65 f f
53 C6H5CH2COOH 1.46 1.81 f f
54 3-Cl-C6H4CH2COOH 2.09 2.48 f f
55 C6H5(CH2)3COOH 2.42 2.63 f f
56 C6H5CH2OH 1.08 1.33 –0.11 –0.13
57 4-Cl-C6H4CH2OH 1.96 2.17 0.19 0.17
58 4-NO2-C6H4-OH 1.92 1.66 f f
59 1,3-C6H4Cl2 3.48 3.88 f 1.33
60 Biphenyl 3.90 4.44 f f
65 N,N-Dimethylbenzylamine 1.91 f 0.73 f
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Second, retention factors of both neutral and basic com-
pounds were measured on Zorbax Extend C18 support
with pH 7.0 and 10.5 mobile phases (Table 6, log k 1 and
log k 4, respectively). Correlations with their log Poct
(pH 7.0) and log D (pH 10.5) were investigated. As both
mobile phases were composed of 40% organic solvent,
slopes and intercepts obtained for neutral compounds
(Eqs. (17), (18)) were similar to those previously obtained
for the two other stationary phases (Eqs. (8)–(11)).
With the pH 7.0 mobile phase:
log Poct = 1.71(l0.31) N log k 1 + 1.00(l0.18)
n = 23, r 2 = 0.86, s = 0.31, F = 128 (17)
With the pH 10.5 mobile phase:
log Poct = 1.80(l0.30) N log k 4 + 1.13(l0.19)
n = 24, r 2 = 0.88, s = 0.35, F = 1598 (18)
The majority of retention factors measured at pH 7.0 for
the basic compounds tested on Zorbax Extend C18support
(Table 6), did not have a good correlation to log D 7:0oct .
J. Sep. Sci. 2005, 28, 2350–2362 www.jss-journal.de i 2005WILEY-VCH Verlag GmbH&Co. KGaA,Weinheim
Table 5. Continued
Numbera) Solute log PNoct
b) log kw;MeOHc) log k 1d) log k 2e)
71 Naphthalene 3.35 3.69 f 1.20
72 1,3,5-C6H3(CH3)3 3.84 h f f
73 n-C9H19COOH 4.09 h f f
75 1,2,4,5-C6H2Cl4 4.51 h f f
77 C6H5(CH2)2C6H5 4.80 h f f
78 C6H(CH3)5 4.56 h f f
a) Same numbering as in [9, 34].
b) Taken from [34].
c) Extrapolated retention factors using methanol as organic modifier.
d) log k measured in mobile phase 1 (MeCN/phosphate buffer pH 7.0 0.0375 M, 40 :60 v/v).
e) log k measured in mobile phase 4 (MeCN/ammonia buffer pH 10.5 0.0315 M, 40 :60 v/v).
f) Not measured.
g) Compound charged under the experimental conditions.
h) Too lipophilic compounds under the experimental conditions.
Table 6. Retention factors of the 14 basic compounds
Number Solute pK a1a) pK a2a) log PNoct
a) log k 1b) log k 4c)
ABZ+Plus Discovery Zorbax Zorbax
40 Pyridine 5.25 0.65 –0.37 –0.39 –0.31 –0.34
81 d-Amphetamine 9.91 1.76 –0.13 –0.37 –0.54 0.11
82 Benzylamine 9.33 1.09 –0.35 –0.37 –0.62 –0.17
83 Chloroprocaine 9.49 2.86 0.15 0.19 –0.05 0.55
84 Codeine 8.10 1.14 0.00 0.09 –0.43 –0.09
85 Diphenydramine 8.98 3.27 0.51 0.58 0.51 1.19
86 Fentanyle 8.43 3.89 0.73 0.67 0.95 1.29
87 Mepivacaine 7.92 1.95 0.28 0.22 0.29 0.44
88 Methadone 8.94 3.93 0.62 0.69 0.60 1.83
89 Morphine 7.93 10.00 0.76 –0.1 –0.11 –0.96 –0.66
90 Nicotine 3.12 8.02 1.17 –0.04 0.10 –0.14 –0.05
91 Nortryptiline 9.73 4.04 0.74 0.73 0.48 1.32
92 Procainamide 9.34 0.88 –0.39 –0.21 –1.40 –0.38
93 Quinine 4.13 8.52 3.55 0.34 0.33 –0.16 0.34
N = pH.
a) Values taken from Medchem [35].
b) log k measured in mobile phase 1 (MeCN/phosphate buffer pH 7.0 0.0375 M, 40 :60 v/v).
c) log k measured in mobile phase 4 (MeCN/ammonia buffer pH 10.5 0.0315 M, 40 :60 v/v).
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Similar to results obtained on Supelcosil ABZ+Plus and
Discovery RP Amide C16 in the same chromatographic
conditions, compounds possessing low pK a value gave
better correlation between log k 1 and log Doct.
With ammonia buffered mobile phase at pH 10.5, the
tested basic compounds were nearly or totally under their
neutral form and secondary interactions with the station-
ary phase greatly reduced. For this reason, the correlation
between log k 4 and log Doct (Table 6) of basic compounds
was closer to the one obtained for neutral compounds
under the same chromatographic conditions. These
results underline that isocratic retention factors of basic
compounds measured in a high-pH mobile phase can
give a suitable estimate of their n-octanol/water partition
coefficients.
4 Concluding remarks
Important correlations were obtained between log Poct and
extrapolated log kw derived from Supelcosil ABZ+Plus,
Discovery RP Amide C16, and Zorbax Extend C18 station-
ary phases. This meant that novel RP-HPLC stationary
phases offer a promising alternative to the shake-flask
method for log Poct determination of compounds in their
neutral form. Good correlations were also established
between log Poct and the three isocratic retention factors
(log k 1, log k 2, and log k 3) for neutral compounds meas-
ured at pH 7.0 and 3.0. However, slopes and intercepts
were not equal to 1 and 0, respectively, showing that iso-
cratic retention factors are not the best estimators of lipo-
philicity.
The results from solvatochromic analyses showed that
the principal factors which govern retention were the van
der Waals volume (Vw) and the hydrogen-bond acceptor
basicity (b) of the solutes, which are also the governing
factors of partitioning in the n-octanol/water system. The
effect of an organic modifier on the free-energy changes
was mostly due to the influence of the organic modifier on
the cavitation energy term, as clearly demonstrated by
volume contribution in LSER analysis.
Finally, results obtained on Zorbax Extend C18 stationary
phase, at high pH and without the addition of a masking
agent, suggested that retention factors of basic com-
pounds could accurately estimate n-octanol/water parti-
tion coefficients, if measured in a mobile phase with high
pH.
The well-known advantages of a chromatographic
method, in particular the small amount of solutes needed,
and automatization suggest that the methods tested here
should be used as a method of primary choice in the phy-
sicochemical screening of large libraries of neutral and
basic compounds.
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Retention Behavior of Neutral and Positively and Negatively Charged Solutes
on an Immobilized-Artificial-Membrane (IAM) Stationary Phase
by Xiangli Liu*a), Hossam Hefeshaa), Gerhard Scribab)1), and Alfred Fahra)
a) Department of Pharmaceutical Technology, Friedrich-Schiller-Universitt Jena, Lessingstrasse 8, D-
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The retention behavior of neutral, positively charged, and negatively charged solutes on the
IAM.PC.DD2 stationary phase was investigated and compared. A set of monofunctional compounds and
complex drugs (steroids, nonsteroidal anti-inflammatory drugs, and b-blockers) were selected for this
study, i.e., neutral solutes and solutes with acidic or basic functionalities which are positively charged or
negatively charged at pH 7.0. The correlation between the retention factor log kw at pH 7.0 on the
IAM.PC.DD2 stationary phase and the partition coefficient log Poct or the distribution coefficient logD7.0
showed that the retention mechanism depends on the charge state and structural characteristics of the
compounds. The neutrals were least retained on the IAM.PC.DD2 stationary phase, and positively
charged solutes were more retained than negatively charged ones. This implies that the retention of the
charged solutes is controlled not only by lipophilicity but also by the electrostatic interaction with the
phospholipid, with which positively charged solutes interact more strongly than negatively charged ones.
Introduction. – Successful drug development requires not only optimization of
specific and potent pharmacological activity at the target site, but also efficient delivery
to that site. Drug design and discovery must take pharmacokinetic behavior into
account, in particular absorption and distribution. Numerous quantitative structure –
permeability-relationship (QSPR) studies have clearly demonstrated that lipophilicity,
as related to membrane partitioning and hence passive transcellular diffusion, is a key
parameter in predicting and interpreting permeability [1] [2]. Lipophilicity is generally
expressed by the octan-1-ol/H2O partition coefficient (log Poct , for a single chemical
species) or distribution coefficient (logDoct , for a pH-dependent mixture of ionizable
compounds). In some studies, a relationship has been established between log Poct (or
log Doct) and the absorption or permeability in intestinal models [3] [4], blood-brain-
barrier models [5], and cell-culture models [6 – 9], to name a few. However, in many
other situations, log Poct (or log Doct) cannot give a good estimate of a drugDs absorption
or permeation [10 – 14]. The lipophilicity parameters log Poct or log Doct fail to encode
some important recognition forces, most notably ionic bonds, which are of particular
importance when modeling the interaction of ionized compounds with biomembranes
[15]. Because the majority of the drugs are ionizable [16], any prediction of their
pharmacodynamic and pharmacokinetic properties should take their ionization into
account.
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Thus the development of membrane-like systems such as immobilized-artificial-
membrane chromatography has been of marked interest in the understanding of
partitioning of ionized compounds [17] [18]. Immobilized artificial membranes (IAMs)
are solid-phase-membrane mimetics prepared by covalently bonding a monolayer of
phospholipids to silica gel particles, thus mimicking the lipid environment of a fluid cell
membrane on a solid matrix. Since IAMs provide the amphiphilic microenvironment of
biological membranes, they should be able to take ionic bonds into account. In
addition, IAM chromatography is a convenient process to measure partitioning of
drugs because it involves the fast HPLC methodology.
The lipophilicity index from a IAM-HPLC stationary phase is derived from the
capacity factor log k, which is calculated by Eqn. 1, where tR and t0 are the retention
times of the solute and of an unretained compound, respectively. For lipophilic
compounds, the retention times would be too long by using a purely aqueous mobile
phase. Thus, log k values are determined at different concentrations of an organic
modifier and extrapolated to pure aqueous mobile phase (log kw) by Eqn. 2, where f is
the volume fraction of MeOH in the mobile phase, S the slope, and log kw the intercept
of the regression curve. For hydrophilic compounds, log kw can be determined directly
by using the aqueous mobile phase.
log k¼ log(tR t0)/t0 (1)
log k¼Sfþ log kw (2)
The interaction of drugs with phospholipids has been investigated by IAM-HPLC
for different sets of neutral and ionized compounds such as b-blockers [19] [20],
nonsteroidal anti-inflammatory drugs [21], and dihydropyridine (DHP) calcium-
channel blockers [22]. In these studies, the log kw values obtained from IAM-HPLC
were compared with the octan-1-ol/H2O partitioning, and the occurrence of electro-
static interactions with phospholipids was found for ionized compounds.
To further understand the retention mechanism of solutes on a IAM stationary
phase, we selected a set of monofunctional compounds and complex drugs (steroids,
nonsteroidal anti-inflammatory drugs, and b-blockers). This set consists of neutral
solutes and solutes with acidic or basic functionalities which are positively charged or
negatively charged at pH 7.0, as shown in the Table. The retention behavior of different
sets of solutes was investigated in terms of the influence of different functionalities,
lipophilicity, and the charged state of the solutes.
Results and Discussion. – To obtain experimental conditions as close as possible to
the physiologic pH and compatible with the stability of the stationary phase (highest
pH limit is 7.5), log k values were determined at pH 7.0 on the IAM.PC.DD2 stationary
phase. According to the pKa values of the compounds shown in the Table, the
monofunctional carboxylic acids 22 – 30 and the NSAIDs 31 – 36 are fully negatively
charged at pH 7.0, whereas the (4-methylbenzyl)alkylamines 37 – 43 and b-blockers
44 – 49 are fully positively charged, and the very weak bases and acids 1 – 5, 12, and 13)
are fully neutral at this pH. The partition coefficient log Poct and distribution coefficient
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Table. The Physicochemical Parameters of the Investigated Compounds 1 – 49. N¼Neutral.
log Poct a) pKa a) logD7.0 b) Charge state log kw c)
1 Acridine 3.40 5.58 3.40 N 2.42
2 PhNH2 0.90 4.60 0.90 N 0.26
3 Ph2NHEt 2.16 5.12 2.16 N 1.04
4 2-ClC6H4NH2 1.91 2.64 1.91 N 1.14
5 2-H2NC6H4Ph 2.84 3.82 2.84 N 2.02
6 PhCH2CN 1.56 N 1.56 N 0.94
7 PhC(O)Me 1.58 N 1.58 N 0.86
8 PhNO2 1.85 N 1.85 N 0.99
9 2-ClC6H4NO2 2.24 N 2.24 N 1.58
10 PhCH2OH 1.08 N 1.08 N 0.58
11 4-ClC6H4CH2OH 1.96 N 1.96 N 1.21
12 3-ClC6H4OH 2.49 9.11 2.48 N 1.77
13 3-O2NC6H4OH 2.00 8.40 1.96 N 1.38
14 Corticosterone 1.94 N 1.94 N 1.67
15 Dexamethasone 1.83 N 1.83 N 1.79
16 Estradiol 4.01 N 4.01 N 2.65
17 Estrone 3.13 N 3.13 N 1.92
18 Hydrocortisone 1.55 N 1.55 N 1,35
19 Hydrocortisone-21-acetate 2.19 N 2.19 N 1.78
20 Progestrone 3.87 N 3.87 N 3.01
21 Testosterone 3.29 N 3.29 N 2.51
22 Ph(CH2)2COOH 1.89 4.52  0.59   0.25
23 Ph(CH2)3COOH 2.42 4.72 0.14  0.06
24 Ph(CH2)4COOH 2.85 4.55 0.40  0.43
25 Ph(CH2)7COOH 4.09 5.03 2.12  2.02
26 PhCOOH 1.96 4.20  0.84   0.62
27 4-BrC6H4COOH 2.86 3.97  0.17  0.32
28 3-ClC6H4COOH 2.71 3.83  0.46  0.06
29 4-IC6H4COOH 3.13 3.96 0.09  0.51
30 1-Naphthoic acid 3.10 3.69  0.21  0.13
31 Aspirin 1.13 3.48  2.39   0.15
32 Flurbiprofen 3.81 3.91 0.72  1.78
33 Ketoprofen 2.77 4.29 0.06  1.26
34 Naproxen 3.06 4.15 0.21  1.35
35 Indomethacin 4.27 4.50 1.77  2.37
36 Mefenamic acid 5.12 4.33 2.45  2.35
37 4-MeC6H4CH2NHMe 1.96 9.93  0.97 þ 0.96
38 4-MeC6H4CH2NHEt 2.38 10.04  0.66 þ 1.02
39 4-MeC6H4CH2NHPr 2.96 9.98  0.02 þ 1.30
40 4-MeC6H4CH2NHBu 3.49 9.98 0.51 þ 1.87
41 4-MeC6H4CH2NH(CH2)4Me 4.26 10.08 1.18 þ 2.27
42 4-MeC6H4CH2NH(CH2)5Me 4.96 10.17 1.79 þ 2.77
43 4-MeC6H4CH2NH(CH2)6Me 5.12 10.02 2.10 þ 2.92
44 Metoprolol 1.95 9.63  0.68 þ 1.45
45 Metipranolol 2.81 9.54 0.27 þ 1.78
46 Oxprenolol 2.51 9.57  0.06 þ 1.70
47 Penbutolol 4.62 9.92 1.70 þ 3.70
48 Pindolol 1.75 9.54  0.79 þ 1.31
49 Propranolol 3.48 9.53 0.95 þ 2.48
a) Taken from [23 – 26]. b) Calculated according to logD¼ log Poct log (1þ 10pKapH) for bases and
logD¼ log Poct log (1þ 10pHpKa ) for acids. c) n¼ 3, s.d. 0.05.
at pH 7.0, namely log D7.0 calculated from pKa and log Poct values, are also summarized
in the Table, together with the pKa values and charge state of the compounds.
Relationship between log k and f. The compounds 22 – 24 and 26 – 31 were eluted
with a purely aqueous mobile phase. For the other solutes, four or five different MeOH
concentrations in aqueous solutions were used as mobile phase for the extrapolation to
log kw values. Good linear relationships between log k and f were found in the range of
the eluent composition studied. The squared correlation coefficient was higher than
0.99, except for the log kw of 3, 4, 10, and 46 (r2¼ 0.98). The log kw values are presented
in the Table together with other physicochemical parameters.
Relationship between log kw and log Poct. The correlation between log kw and log Poct
is shown in Fig. 1. No correlation exists for the whole set of compounds. However, the
correlations are good for neutral compounds or structurally related compounds. The
corresponding correlation equations are shown as follows below (Eqns. 3 – 7), wherein
95% confidence limits are in parentheses, n is the number of compounds, r2 the squared
correlation coefficient, s the standard deviation, and F FisherDs test.
For the neutral compounds 1 – 21, Eqn. 3 holds (n¼ 21, r2¼ 0.87, s¼ 0.26, and F¼
130). The correlation coefficient for the 13 monofunctional solutes 1 – 13 became
much more significant (r2¼ 0.95) if the steroids 14 – 21 (see Table) were excluded,
implying that the correlation quality for neutral compounds is decreased by the
increasing structural diversity of the complex drugs.
log kw¼ 0.77 (0.13) log Poct 0.19 (0.33) (3)
For the b-blockers 44 – 49, Eqn. 4 holds (n¼ 6, r2¼ 0.97, s¼ 0.18, and F¼ 115). As
shown in Eqn. 4 and Fig. 1, the six b-blockers fit the correlation line for neutral
compounds. This agrees with the study of Barbato et al. [19]. It means that the b-
blockers under study can interact with phospholipids as strongly as neutral compounds
with the same log Poct values, although they are fully positively charged under the
Fig. 1. Correlation between log kw values from the IAM.PC.DD2 stationary phase at pH 7 and log Poct
values for the compounds investigated
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experimental conditions. It suggests that the retention of the six b-blockers on the
IAM.PC.DD2 stationary phase is governed not only by lipophilicity but also by extra
interactions of which an electrostatic interaction between positively charged amines
and negatively charged phosphates of the phospholipids plays a key role, as discussed
by Avdeef et al. [27] and Barbato et al. [19] [28] in their studies.
log kw¼ 0.84 (0.16) log Poct 0.34 (0.48) (4)
For the (4-methylbenzyl)alkylamines 37 – 43, Eqn. 5 holds (n¼ 7, r2¼ 0.98, s¼ 0.11,
and F¼ 320). The retention of these seven positively charged (4-methylbenzyl)alkyl-
amines on the IAM.PC.DD2 stationary phase is weaker than that of the b-blockers and
neutral compounds with same log Poct values, as shown by Eqn. 5 and Fig. 1, implying
that the strength of extra interactions between charged amines and the phospholipid
membrane depends on the structural characteristics of the solutes.
log kw¼ 0.65 (0.07) log Poct 0.46 (0.27) (5)
For the NSAIDs 31 – 36, Eqn. 6 holds (n¼ 6, r2¼ 0.95, s¼ 0.24, and F¼ 73). The
retention of the negatively charged NSAIDs and monofunctional carboxylic acids
investigated is weaker than that of positively charged compounds. Contrary to the
result from the study of Barbato et al. on the IAM.PC.MG stationary phase [21], where
the correlation between log kw and log Poct results in a unique regression line for
NSAIDs (with carboxylic function not directly linked to the aromatic ring) and neutral
compounds, our study on the IAM.PC.DD2 stationary phase showed two separate
regression lines for NSAIDs and neutral compounds, implying that the NSAIDs
investigated are less retained than neutral compounds with same log Poct values. It
should be noted that the retention behavior of the negatively charged NSAIDs,
especially of 32 – 35, is very similar to that of the positively charged (4-methylbenzyl)-
alkylamines.
log kw¼ 0.66 (0.16) log Poct 0.72 (0.55) (6)
For the monofunctional carboxylic acids 22 – 30, Eqn. 7 holds (n¼ 9, r2¼ 0.86, s¼
0.29, and F¼ 43). These negatively charged carboxylic acids, except for 25, are less
retained than negatively charged NSAIDs, resulting in a different regression line
between log kw and log Poct. The correlation coefficient of Eqn. 7 is low, meaning that
the retention behavior of this set of compounds cannot be well predicted by their
log Poct values.
log kw¼ 1.02 (0.31) log Poct 2.54 (0.89) (7)
Relationship between log kw on the IAM.PC.DD2 and logD7.0 . The log Poct and
log D7.0 values are highly interrelated for (4-methylbenzyl)alkylamines and NSAIDs
investigated in this study; therefore, the relationship between log kw and log D7.0 values
is not reported anymore here. The correlation between log kw and log D7.0 values for b-
blockers is less significant than that between log kw and log Poct . However, for the
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monofunctional carboxylic acids, a much more significant correlation equation is
established between log kw and log D7.0 values (see Eqn. 8, n¼ 9, r2¼ 0.94, s¼ 0.19, and
F¼ 107), as compared to Eqn. 7. It indicates that the retention can be much better
predicted by the distribution coefficient logD7.0 values for this set of compounds.
log kw¼ 0.82 (0.16) log D7.0þ 0.25 (0.13) (8)
The extra interaction between ionized solutes and the IAM.PC.DD2 stationary
phase can be more clearly and logically shown in Fig. 2, the correlation between log kw
and the distribution coefficient logD7.0 of the compounds investigated. From Fig. 2, it
can be seen that the neutral compounds are the least retained on the IAM.PC.DD2
stationary phase. All the ionized solutes are more strongly retained than neutral ones
with the same log D7.0 values, to a different extent, depending on their charge and
structural characteristics. The retention of positively charged solutes is stronger than
that of negatively charged ones. Indeed, as discussed by Avdeef et al. in the liposomal
membrane/water partitioning of ionized drugs [27], the charge distribution in the
phospholipid membrane is anisotropic; as the ionized species moves in the direction of
the aqueous exterior of the membrane, the first charges it experiences are those of the
negatively charged phosphates. Further movement would bring the ionized drug
substance in the vicinity of the positively charged trimethylammonium groups.
Electrostatic pairing of charges would require a greater movement for weak acids,
compared to weak bases. Therefore, the negatively charged solutes have lesser affinity
for phosphatidylcholine-based membranes than positively charged solutes. The results
from our study with the IAM.PC.DD2 stationary phase verified this point. Further,
Fig. 2 shows that the retention of the ionized solutes on the IAM.PC.DD2 phase also
depends on their structural characteristics. For the positively charged amines
investigated, b-blockers are slightly more retained than (4-methylbenzyl)alkylamines,
which is also shown by Taillardat –Bertschinger et al. in their study [24]. For the
negatively charged solutes, NSAIDs (except for mefenamic acid (36)) are more
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Fig. 2. Correlation between log kw values from the IAM.PC.DD2 stationary phase at pH 7 and logD7.0
values for the compounds investigated
retained than monofunctional carboxylic acids, confirming that the strength of the
electrostatic interactions is influenced by different structural characteristics of the
solutes.
Conclusion. – In this work, we compared the retention behavior of a set of neutral
and positively or negatively charged solutes on the IAM.PC.DD2 stationary phase.
Significant correlations were found between the retention factor log kw on this
stationary phase and log Poct or log D7.0 for neutral or structurally related compounds,
implying that the retention mechanisms are the same for neutral or structurally related
compounds. The retention of the ionized compounds on the IAM.PC.DD2 is controlled
not only by lipophilicity but also by extra interactions, mainly electrostatic interactions
between charged solutes and phospholipids. For the solutes investigated in this study,
positively charged compounds are more retained than negatively charged solutes. The
ranking order of retention strength is: b-blockers> (4-methylbenzyl)alkylamines>
NSAIDs>monofunctional carboxylic acids. This implies that the interaction between
positively charged solutes and the phosphatidylcholine-based IAM stationary phase is
larger than that between negatively charged solutes and the membrane, and that the
electrostatic interaction depends on the structural characteristics of the solutes
investigated.
The authors thank Prof. Bernard Testa, University of Lausanne, for his critical review of the
manuscript and Mrs. Martina Hense for assistance preparing the (4-methylphenyl)alkylamines.
Experimental part
General. The (4-methylbenzyl)alkylamines 37 – 43 (Table) were synthesized by known procedures
[29]. All other compounds were obtained from commercial sources (Sigma –Aldrich, Steinheim,
Germany; Carl Roth, Karlsruhe, Germany; VWR, Leuven, Belgium) in the highest available purity.
Distilled H2O, HPLC-grade MeOH (Alfa Aesar, Karlsruhe, Germany) were used throughout.
Capacity Factors. The capacity factors were measured with a liquid chromatograph equipped with a
HPLC pump System-Gold-125 solvent module, a System-Gold-507e autosampler, and a System-Gold-
UV/VIS-168 detector (all from Beckmann Coulter, Inc., Fuerton, CA, USA). The column was an
IAM.PC.DD2 (100 mm 4.6 mm i.d., 10 mm) from Regis Technology (Morton Grove, IL, USA). The
mobile phases were either 0.02m phosphate buffer pH 7.0 or mixtures of 0.02m phosphate buffer pH 7.0
and MeOH in proportions varying from 70 to 10% (v/v) for all other compounds. The phosphate buffer
was filtered under vacuum through aHA-Millipore filter (0.45mm;Millipore, Milford, MA, USA) before
being mixed withMeOH. The retention times were measured at r.t. by the UV/VIS detector at the lmax of
the analytes. The solns. to be injected (104 m to 103 m) were prepared by dissolving the solutes in the
mobile phase; the injection volume was 10 ml. Citric acid was used as the unretained compound. The
measurements were carried out at a flow rate of 1.0 ml/min for all compounds. For compounds 22 – 24 and
26 – 31, the log kw values were determined directly in the aq. mobile phase. For the other compounds, four
or five different MeOH concentrations in aq. soln. were used as mobile phase for the extrapolation to
log kw. The capacity factor log k was calculated by Eqn. 1. All log k values were the average of three
measurements. The log k values were then extrapolated to 100% H2O with Eqn. 2 (! log kw).
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Drug –Membrane Interaction on Immobilized Liposome Chromatography
Compared to Immobilized Artificial Membrane (IAM), Liposome/Water, and
Octan-1-ol/Water Systems
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The objective of this study was to investigate drug –membrane interaction by immobilized liposome
chromatography (ILC; expressed as lipophilicity index log Ks) and the comparison with lipophilicity
indices obtained by liposome/H2O, octan-1-ol/H2O, and immobilized artificial membrane (IAM)
systems. A set of structurally diverse monofunctional compounds and drugs (nonsteroidal anti-
inflammatory drugs and b-blockers) were selected in this study. This set of solutes consists of basic or
acidic functionalities which are positively or negatively charged at physiological pH 7.4. No correlation
was found between log Ks from ILC and lipophilicity indices from any of the other membrane model
systems for the whole set of compounds. For structurally related compounds, significant correlations
could be established between log Ks from ILC and lipophilicity indices from IAM chromatography and
octan-1-ol/H2O. However, ILC and liposome/H2O systems only yield parallel partitioning information
for structurally related large molecules. For hydrophilic compounds, the balance between electrostatic
and hydrophobic interactions dominating drug partitioning is different in these two systems.
Introduction. – Successful drug development requires not only the optimization of
the specific and potent pharmacological activity at the target site, but also efficient
delivery of the compounds to that site. Drug design and discovery must take
pharmacokinetic behavior into account, in particular absorption and distribution.
Numerous quantitative structure – permeability relationship (QSPR) studies have
clearly demonstrated that lipophilicity, as related to membrane partitioning and hence
passive transcellular diffusion, is a key parameter in predicting and interpreting
permeability [1] [2]. Lipophilicity is generally expressed by the octan-1-ol/H2O
partition coefficient (log Poct , for a single chemical species) or distribution coefficient
(log Doct , for a pH-dependent mixture of ionizable compounds). In some studies, a
relationship has been established between log Poct (or log Doct) and absorption or
permeability in intestinal models [3] [4], blood-brain-barrier models [5], and cell-
culture models [6 – 9], to name a few. However, in many other situations, log Poct (or
log Doct) cannot give a good estimate of a drugs absorption or permeation [10 – 14].
The lipophilicity parameters log Poct or log Doct fail to encode some important
recognition forces, most notably ionic bonds, which are of particular importance when
modeling the interaction of ionized compounds with biomembranes [15]. Because the
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majority of the drugs are ionizable [16], any prediction of their pharmacodynamic and
pharmacokinetic properties should take their ionization into account.
Thus, the development of membrane-like systems such as liposome/H2O partition-
ing systems [17] [18] has been of marked interest to obtain lipophilicity parameters of
greater biologic relevance, especially for ionized compounds. However, the determi-
nation of drug partitioning in liposome/H2O systems is time-consuming and tedious,
and, therefore, of little use in medium or high-throughput screening in drug discovery.
As surrogates, immobilized artificial membrane (IAM) chromatography [18 – 21] and
immobilized liposome chromatography (ILC) [22 – 24] were recently developed as
convenient and rapid methods for the analysis of drug –membrane interactions.
However, it was shown for a set of structurally unrelated compounds that IAM
retention and liposome/H2O partitioning are governed by a different balance of
intermolecular interactions, and, thus, the lipophilicity index from IAM retention is not
exchangeable with that from liposome/H2O partitioning for structurally unrelated
compounds [18] [25].
In the present study, we aimed to investigate the lipophilicity index from ILC and its
comparison to lipophilicity indices obtained from liposome/H2O, octan-1-ol/H2O, and
IAM membrane model systems. In ILC, liposomes are entrapped in the pores of gel
beads which are packed into HPLC columns. The lipophilicity index from ILC is
expressed as the capacity factor log Ks, which is calculated according to Eqn. 1,
log Ks¼ log [(VRV0)/A] (1)
whereVR andV0 are the retention volumes of the drug and of an unretained compound,
respectively, and A is the amount of immobilized phospholipids. Some studies have
shown that ILC is a useful method for the study or rapid screening of drug –membrane
interactions [22 – 24]. sterberg et al. demonstrated a good correlation between the
lipophilicity index determined by ILC (log Ks) and the lipophilicity index from a
liposome/H2O system, while a poor correlation with the index from the octan-1-ol/H2O
system and a moderate correlation with the index from IAM chromatography was
observed for a chemically diverse set of drugs [25].
To further understand the relationship between the lipophilicity indices from
different membrane model systems, we selected a set of 22 structurally diverse
monofunctional compounds (alkyl(4-methylbenzyl)amines and carboxylic acids; 1 –
22) and drugs (nonsteroidal anti-inflammatory drugs and b-blockers), which are
positively charged or negatively charged at the physiological pH 7.4.We determined the
lipophilicity index log Ks by ILC with immobilized large unilamellar egg-phosphati-
dylcholine (egg PC) liposomes and compared it to published partitioning data from
liposome/H2O, octan-1-ol/H2O, as well as IAM chromatography.
Results and Discussion. – Stability of ILC Column. Two reference compounds (5
with a log Poct value of 4.26 and 11 with a log Poct value of 1.95) were used to determine
the stability of the column. The log Ks values did not change significantly over the time
of the measurements (four weeks). This indicates that this immobilized liposome
column is stable under the experimental conditions at the flow rate of 0.2 ml/min used
in this study.
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Physicochemical Parameters. The log Ks values determined by ILC with immobi-
lized large unilamellar egg PC liposomes, as well as published lipophilicity indices from
liposome/H2O (log D7:0lip ), octan-1-ol/H2O (log PNoct and log D7:0oct ) and IAM chromatog-
raphy (log k7:0IAMw) are summarized in the Table. The log D7:0lip values (distribution
coefficient at pH 7.0) were determined using large unilamellar egg PC liposome/H2O by
potentiometric titration [18].
The log k7:0IAMw values (capacity factor at pH 7.0) were obtained from experiments
using an IAM.PC.DD2 HPLC column [21]. The octan-1-ol/H2O partitioning data
(log PNoct and log D7:0oct ) were taken from the literature [21]. According to the pKa values
of the compounds [21], the alkyl(4-methylbenzyl)amines and b-blockers (compounds
1 – 14) are fully positively charged, whereas the monofunctional carboxylic acids and
NSAIDs (compounds 15 – 22) are fully negatively charged at both pH 7.4 and 7.0.
Comparison between log Ks and log D7:0lip Values. For the basic compounds; 1 – 14, of
which the log D7:0lip values are available, the correlation between log Ks and log D7:0lip
values is shown in Fig. 1. In contrast to the result from the study ofsterberg et al. [25],
no correlation could be found for the whole set of basic compounds between these two
lipophilicity indices, although the same type of phospholipid (egg PC) liposome was
used in both systems. Good correlation was found for the b-blockers, i.e., 8 – 14. The
correlation Eqn. is:
Table. Physicochemical Parameters of the Compounds under Study
Solutes log Poct a) logD7:0oct a) log k7:0IAMw a) logD7:0lip b) log Ks c)
1 4-MeC6H4CH2NHMe 1.96  0.97 0.96 2.54 0.95
2 4-MeC6H4CH2NHEt 2.38  0.44 1.02 2.26 0.96
3 4-MeC6H4CH2NHPr 2.96 0.15 1.30 2.11 1.13
4 4-MeC6H4CH2NHBu 3.49 0.67 1.87 1.55 1.41
5 4-MeC6H4CH2NH(CH2)4Me 4.26 1.32 2.27 1.86 1.85
6 4-MeC6H4CH2NH(CH2)5Me 4.96 1.91 2.77 2.45 2.34
7 4-MeC6H4CH2NH(CH2)6Me 5.12 2.21 2.92 2.73 2.88
8 Acebutolol 2.02  0.20 1.57 1.93 0.88
9 Alprenolol 3.10 0.70 2.25 2.33 2.19
10 Metipranolol 2.81 0.38 1.78 2.27 1.81
11 Metoprolol 1.95  0.54 1.45 1.59 1.02
12 Oxprenolol 2.51 0.21 1.70 2.09 1.48
13 Penbutolol 4.62 1.85 3.70 3.39 3.45
14 Propranolol 3.48 1.17 2.48 2.69 2.64
15 Ph(CH2)2COOH 1.89  0.59  0.25 0.37
16 Ph(CH2)4COOH 2.85 0.40 0.43 0.80
17 Ph(CH2)7COOH 4.09 2.12 2.02 2.09
18 Flurbiprofen 3.81 0.72 1.78 2.08
19 Indomethacin 4.27 1.77 2.37 2.48
20 Ketoprofen 2.77 0.06 1.26 1.38
21 Mefenamic acid 5.12 2.45 2.35 2.93
22 Naproxen 3.06 0.21 1.35 1.56
a) Taken from [21]. b) Taken from [18]. c) Determined at pH 7.4 in this study, n¼ 3, SD 0.05.
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log Ks¼ 1.52 (0.38) log D7:0lip  1.62 (0.90) (2)
n¼ 7, r2¼ 0.93, s¼ 0.26, F¼ 66
In this and the following Eqns., 95% confidence limits are in parentheses, n is the
number of compounds, r2 the squared correlation coefficient, s the standard deviation,
and F Fishers test. The significant correlation implies that the retention on the ILC
column with immobilized egg PC liposome and partitioning in egg PC liposome/H2O
are controlled by the same balance of intermolecular interactions for the seven b-
blockers.
No correlation was observed for the alkyl(4-methylbenzyl)amines 1 – 7. Instead, a
bilinear relationship between log Ks and log D7:0lip values was found with a positive slope
for compounds 5 – 7 and a negative slope for compounds 1 – 3, which indicates that
different balances of intermolecular interactions dominate the retention in the ILC and
partitioning in liposome/H2O for this set of compounds. As pointed out in one study
[26], hydrophobic interactions dominate the partitioning for bulkier compounds 5 – 7,
whereas electrostatic interactions dominate the partitioning for the solutes with shorter
alkyl chains, i.e., compound 1 – 3 in liposome/H2O systems. The present results indicate
that electrostatic interactions play a smaller role in ILC than in liposome/H2O
partitioning. Therefore, the lipophilicity index from ILC is not exchangeable with that
from the liposome/H2O partitioning for this set of compounds, as well as for structurally
unrelated compounds. The reasons for this observation are not understood and need
further investigation.
Comparison between log Ks and log k7:0IAMw Values. No correlation was observed
between log Ks and log k7:0IAMw values for the present set of 22 compounds (Fig. 2),
indicating that the two systems do not yield comparable lipophilicity parameters for
structurally unrelated drugs. This result is in agreement with a previous study [25],
where only a weak correlation was found between log Ks values on ILC with
immobilized phosphatidylcholine (PC) liposome and log k7:0IAMw values on IAM.PC.MG
Fig. 1. Correlation between log Ks and logD7:0lip values for the 14 basic compounds investigated
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HPLC column for a set of NSAIDs, local anaesthetics and b-blockers. One possible
reason for the difference between the lipophilicity indices from these two anisotropic
chromatographic systems is the different density of the polar phospholipid head-
groups, which was established as an important factor for drug partitioning in biological
and artificial membranes [20].
However, significant correlations were found for the basic compounds, 1 – 14, as
shown in Eqn. 3, and for the acidic compounds, 15 – 22, as shown in Eqn. 4.
For basic compounds 1 – 14 :
log Ks¼ 0.98 (0.16) log k7:0IAMw 0.19 (0.36) (3)
n¼ 14, r2¼ 0.92, s¼ 0.24, F¼ 134
For carboxylic acids 15 – 22 :
log Ks¼ 0.90 (0.16) log k7:0IAMwþ 0.44 (0.28) (4)
n¼ 8, r2¼ 0.95, s¼ 0.20, F¼ 117
These significant correlations indicate that the balance of intermolecular inter-
actions (mainly hydrophobic and electrostatic) in ILC and IAM chromatography is
similar for the positively charged basic compounds or negatively charged acidic
compounds investigated. In other words, the lipophilicity index by ILC is interchange-
able with that by IAM chromatography for structurally related compounds. For the
basic compounds investigated, ILC system is more similar to IAM chromatography
than to liposome/H2O partitioning system.
The similar slopes and different intercepts of Eqns. 3 and 4 are probably caused by
the different balance of electrostatic interactions of different ion types in these two
Fig. 2. Correlation between log Ks and log k7:0IAMw values for the compounds investigated
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membrane systems. However, more investigations are necessary to reach a sound
conclusion.
Comparison between log Ks and log Poct or log D7:0oct Values. The comparison between
the log Ks and log Poct values is shown in Fig. 3,a, for compounds 1 – 22. No correlation
exists for the complete set of compounds, but good correlations are detected for
structurally related sets of alkyl(4-methylbenzyl)amines, b-blockers, and carboxylic
acids as shown in Eqns. 5 – 7.
For alkyl(4-methylbenzyl)amines 1 – 7:
log Ks¼ 0.58 (0.16) log Poct 0.42 (0.58) (5)
n¼ 7, r2¼ 0.92, s¼ 0.24, F¼ 54
For b-blockers 8 – 14 :
log Ks¼ 0.98 (0.12) log Poct 0.94 (0.36) (6)
n¼ 7, r2¼ 0.98, s¼ 0.13, F¼ 289
For carboxylic acids 15 – 22 :
log Ks¼ 0.81 (0.16) log Poct 1.10 (0.60) (7)
n¼ 8, r2¼ 0.94, s¼ 0.23, F¼ 93
The good quality of Eqn. 5 demonstrates that for the alkyl(4-methylbenzyl)amines
series, the intermolecular interactions underlying the retention in ILC are closer to
those in octan-1-ol/H2O compared to those in egg PC liposome/H2O. The significant
correlations shown in Eqns. 5 – 7 indicate that log Ks values obtained by the anisotropic
ILC system can be predicted by the traditional log Poct values for the three sets of
structurally related compounds.
Fig. 3,a, shows that b-blockers which are positively charged at the experimental
conditions are retained strongest on the ILC column among the three sets of solutes.
The same result was also found for IAM chromatography [21]. This suggests that the
interaction of ionized drugs with immobilized liposomes depends not only on their
lipophilicity expressed as log Poct , but also on additional interactions including
electrostatic interactions and their ability to form H-bonds with the polar head groups
of the phospholipids (b-blockers can form more H-bonds than alkyl(4-methylbenzyl)-
amines). The strength of these additional interactions depends on the structural
characteristics of the drugs, as clearly indicated in Fig. 3.
It was found that positively charged solutes are more retained than negatively
charged solutes on an IAM.PC.DD2 stationary phase [21], which was explained as the
result of a larger affinity of positively charged drugs to phospholipid membranes
compared to the negatively charged compounds. However, we did not obtain the same
results by ILC with immobilized unilamellar egg PC liposomes in this study. As shown
in Fig. 3, some carboxylic acids which are negatively charged at the experimental
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conditions are retained stronger than alkyl(4-methylbenzyl)amines which are pos-
itively charged at pH 7.4. This implies that the drugs do not interact with phospholipid
membranes in ILC in the same way as in IAM chromatography. Thus, further
investigations on the factors which influence drug –membrane interactions in different
membrane model systems are required.
The log Poct and log D7:0oct values are highly interrelated for the alkyl(4-methyl-
benzyl)amines and b-blockers. Therefore, the correlations between log Ks and log D7:0oct
values are also significant for these two sets of solutes (r2 0.91 and 0.97, resp.). However,
no correlation exists for the whole set of acidic compounds between these two
parameters. Good correlations were established only for NSAIDs (r2 0.97) and
monofunctional carboxylic acids (r2 0.98) as shown in Fig. 3,b.
Conclusions. – In this work, we investigated drug –membrane interactions by ILC
with immobilized large unilamellar egg PC liposomes, and compared them with
Helvetica Chimica Acta – Vol. 93 (2010) 209
Fig. 3. Correlation between log Ks and log Poct (a) or logD7:0oct (b) values for the compounds investigated
lipophilicity indices from liposome/H2O, octan-1-ol/H2O, and IAM chromatography, by
using a set of monofunctional compounds and drugs which are positively or negatively
charged under the experimental conditions. For the whole set of solutes, the
lipophilicity index log Ks from ILC was not exchangeable with those from any of the
other membrane model systems. For subsets of structurally related compounds,
significant correlations were found between log Ks values and the lipophilicity indices
obtained by IAM chromatography and octan-1-ol/H2O, indicating that a comparable
balance of intermolecular forces dominate the drug –model membrane interactions for
structurally related solutes. However, for the basic compounds investigated, 1 – 14,
good correlations were only found between lipophilicity indices from ILC and egg PC
liposome/H2O for large molecules (b-blockers and long-chain alkyl(4-methylbenzyl)-
amines, 5 – 7), implying that different balances of hydrophobic and electrostatic
interactions dominate the partitioning of drugs in these two systems. Electrostatic
interactions play a smaller role in ILC than in liposome/H2O.
Experimental Part
General. The alkyl(4-methylbenzyl)amines (1 – 7 in the Table) were synthesized according to known
procedures [27]. All other test compounds were obtained from commercial sources (Sigma-Aldrich, D-
Steinheim; Carl Roth, D-Karlsruhe; VWR, B-Leuven) in the highest available purity. Dist. H2O was used
throughout. Superdex 200 prep. grade and glass column (HR 5/5) were bought from Amersham (S-
Uppsala). Egg phosphatidylcholine (egg PC) was purchased from Lipoid (D-Ludwigshafen).
Measurement of Capacity Factors. The capacity factors were measured with a liquid chromatograph
Merck L-6200 A separation module equipped with a UV/VIS detector L-4250 (Merck-Hitachi Ltd.,
Tokyo, Japan).
Liposomes were prepared by rehydration of lipid films in 150 mm NaCl, 1 mm Na2EDTA and 10 mm
Tris · HCl, pH 7.4 (to obtain an egg PC concentration of 100 mmol/l). The liposome suspension was
extruded 15 times through a polycarbonate filter having 100 nm pores (Avestin Europe, D-Mannheim).
The size distribution was controlled by dynamic light scattering using a Zetasizer Nano ZES3600
(Malvern Instruments Inc., UK). The developed large unilamellar liposomes were mixed with thoroughly
dried Superdex 200 prep. grade gel beads (1.5 ml of suspension to 110 mg of beads) and immobilized by
gel bead swelling for 5 h at r.t. The material was packed into a 5-mm (I. D.) glass column to a 1.2 ml gel
bed. The amount of phospholipid (A in Eqn. 1) was determined as the phosphorus amount in the gel
suspension [28]. Lipid content in the liposome column after the retention analyses was 18.7 mmol.
The mobile phase was 10 mm Tris ·HCl buffer with 150 mm NaCl and 1 mm Na2EDTA, pH 7.4,
filtered under vacuum through a 0.45 mm HA Millipore filter (Millipore, Milford, MA, USA) and
degassed before analysis. The flow rate was 0.2 ml/min. The retention times were measured at r.t. by the
UV/VIS detector at 250 nm.
The analyte solns. (104 to 103 m) were prepared by dissolving the solutes in the mobile phase or in
EtOH, and diluted with the mobile phase (> 5% EtOH) in the case of lipophilic compounds. The
injection volume was 10 ml. K2Cr2O7 was used as the unretained compound to obtain V0.
The capacity factor log Ks was calculated according to Eqn. 1. All log Ks values are the averages of
three measurements.
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